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ABSTRACT 
 
Turnover of focal adhesions (FAs) is known to be critical for cell migration and 
adhesion of proliferative vascular smooth muscle cells (VSMCs). However, it is often 
assumed that FAs in non-migratory, differentiated vascular smooth muscle cells 
(dVSMCs) embedded in the wall of healthy blood vessels are static structures. Recent 
work from our laboratory has demonstrated agonist-induced actin polymerization and 
Src-dependent focal adhesion phosphorylation in dVSMCs, suggesting that agonist-
induced FA remodeling occurs. However, the mechanisms and extent of FA remodeling 
are largely unknown in dVSM. Here I show, for the first time, that a distinct 
subpopulation of dVSM FA proteins, but not the entire FA, remodels in response to the 
 viii 
alpha-agonist phenylephrine. VASP and Zyxin displayed the largest redistributions while 
beta-integrin and focal adhesion kinase (FAK) showed undetectable redistribution. 
Vinculin, metavinculin, Rous sarcoma oncogene (Src), p130Crk-associated substrate 
(CAS), and paxillin displayed intermediate degrees of redistribution. Redistributions into 
membrane fractions were especially prominent, suggesting endosomal mechanisms. 
Deconvolution microscopy, quantitative colocalization analysis, and proximity ligation 
assays revealed that phenylephrine (PE) increases the association of FA proteins with 
early endosomal markers Rab GTPase 5 (Rab5) and early endosome antigen 1 (EEA1). 
Endosomal disruption with the small molecule inhibitor primaquine inhibits agonist-
induced redistribution of FA proteins, confirming endosomal recycling.  FA recycling 
was also inhibited by cytochalasin D, latrunculin B and colchicine, indicating that the 
redistribution is actin and microtubule-dependent. Furthermore, inhibition of endosomal 
recycling causes a significant inhibition of the rate of development of agonist-induced 
dVSM contractions. Thus, these studies are consistent with the concept that FAs in 
dVSMCs, embedded in the wall of the aorta, remodel during the action of a 
vasoconstrictor. 
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CHAPTER 1: INTRODUCTION 
 
INTRODUCTION 
Aberrant differentiated vascular smooth muscle contraction (VSM) is an 
important contributor in the pathogenesis of cardiovascular disease.  However, not much 
is known about the mechanisms and pathways involved in stimulus-induced contraction 
in this cell phenotype.  In non-contractile, migrating cells protein complexes known as 
focal adhesions (FAs) are responsible for mechanical linkages of the cell to the 
extracellular matrix (ECM) as well as transmitting outside-in and inside-out signals.  This 
thesis focuses on the role of focal adhesions (FAs) in differentiated vascular smooth 
muscle (dVSM). 
 
CARDIOVASCULAR DISEASES 
Cardiovascular disease is the leading cause of death in the United States (119).  
As part of the cardiovascular circulatory system, VSM needs to be highly dynamic and 
versatile to adapt to the changing cellular environment (Figure 1.1); however, it is known 
that phenotypic abnormalities in VSM make key contributions to atherosclerosis and 
hypertension, which can then further aggravate or accelerate other, more serious 
cardiovascular conditions and increase the risk of stroke or heart failure (29, 54, 169).  In 
fact, primary hypertension is present in more than 90% of cardiovascular disease cases 
(27).  Several of the standard treatments involve inhibiting vascular tone and reducing 
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vasoconstriction in VSM (55).  Therefore, it is critical to understand the mechanisms for 
VSM maintenance of mass, tone, lumen, and contractile capacity (183). 
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Figure 1.1.  Role of blood vessels.  Breakdown of the dynamic role of blood vessels in 
response to the changing cellular environment.  Schematic of specific blood vessel 
response and remodeling as a part of normal cellular processes, vascular injury, adaptive 
response, or contribution to disease pathology.  Modified from Humphrey, 2008 (103). 
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VASCULAR SMOOTH MUSCLE 
In a closed circulatory system, large arteries and the smaller associated 
microvessels play an important role in directing blood flow and regulating blood pressure 
through alternating constriction and dilation of vessels (10, 137, 210).  This effect is 
achieved primarily by the drastic contraction of vascular smooth muscle cells (VSMCs) 
which reside in the tunica media, oriented perpendicular to the direction of the overall 
vessel (210) (Figure 1.2).  This contraction occurs via a substantial rearrangement of the 
cytoskeleton, allowing cells to shorten to 50% of their original length (209) (Figure 1.3).  
However, much about the signaling pathways and importance of the individual protein 
constituents involved in cytoskeletal rearrangement remains undiscovered. 
 VSM contraction can be achieved through chemical, mechanical, or electrical 
stimulation.  Although all contractile stimuli ultimately affect myosin and/or actin to 
control cross-bridge cycling, there are several different possible signaling pathways that 
can be used to arrive at the final target, including both Ca
2+
-dependent and independent 
pathways in differentiated vascular smooth muscle (dVSM) (209) (Figure 1.4).  Myosin 
regulation is accomplished almost exclusively through phosphorylation of myosin 
regulatory light chain (36) whereas actin availability can be controlled by a variety of 
actin-binding proteins. 
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Figure 1.2 Structure of blood vessels.  Diagrammatic representation of the different cell 
layers of an artery.  The thin, innermost intima layer adjacent to the lumen consists of 
endothelial cells and a layer or two of fenestrated elastic membrane making up the 
elastica interna.  The middle (media) layer is the thickest layer and is comprised primarily 
of smooth muscle cells. The outermost adventitial layer is made up of extracelluar matrix 
and fibroblast cells. (reproduced for free from 
http://commons.wikimedia.org/wiki/File:Anatomy_artery.png). 
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Figure 1.3 Vascular smooth muscle contraction.  Time lapse phaselucent microscope 
image sequence demonstrating the remarkable contractile capability of VSMCs.  
Stimulation of an enzymatically isolated dVSMC with 10 M phenylephrine results in 
visible cellular contraction over a short period of time to less than 50% of initial cell 
length.  Modified from Vetterkind and Morgan, 2012 (209). 
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Figure 1.4 Smooth muscle stimuli and signaling pathways.  Diagrammatic 
representation of the various stimuli that can cause a contractile response and the 
different pathways through which that response can be achieved in dVSM.  Mechanical, 
chemical, or electrical stimuli result in cellular contraction through a Ca
2+
-independent 
increase in actin availability and/or Ca
2+
-dependent myosin activation by myosin light 
chain kinase.  Modified from Vetterkind and Morgan, 2012 (209). 
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Vascular Smooth Muscle Phenotypes 
VSMCs can exist in either proliferative, migratory, non-contractile phenotype or a 
fully differentiated, non-migratory, contractile phenotype (161) (Figure 1.5).  Ordinarily, 
proliferative VSMCs are necessary for embryogenesis and angiogenesis, but uncontrolled 
division has been implicated in atherosclerosis and hypertension (11, 100).  Similarly, the 
fully differentiated, contractile VSMCs are required for regulation of blood flow and 
pressure but dysfunction can contribute to hypertension, stroke, and heart failure (214).  
However, these quiescent, differentiated cells can transform back into a proliferative state 
in response to inflammatory signals or growth factors (145) and consequently further 
contribute to the pathogenesis of disease (11, 129).  Much of what is known has come 
through the study of VSMCs in culture, so comparatively little is known about 
contractile, dVSMCs. 
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Figure 1.5 Contractile versus migrating smooth muscle.  Labeled microscopic images 
showing some of the differences between synthetic and contractile VSMCs.  Contractile 
VSMCs (right) are elongated, spindle-shaped cells.  Upon being cultured, VSMCs de-
differentiate into a proliferative, migratory synthetic phenotype (left), losing their 
elongated cell shape and contractile filaments.  The number and size of organelles 
involved in protein synthesis increases in the de-differentiated, synthetic phenotype.  
Modified from Rensen et al, 2007 (161). 
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Differentiated Vascular Smooth Muscle 
This study focuses on differentiated as opposed to cultured cells, which 
necessitates an extra investment of time to dissociate cells with a smaller net yield as well 
as developing specialized techniques for this system.  However, it is well known that 
dVSMCs undergo a phenotypic change when grown as immortalized cells (19, 80, 123, 
161, 205).  DVSMCs de-differentiate and in the process lose normal contractile 
responses, assemble a microtubule network, and alter signaling pathways (94).  Since it is 
the fully differentiated, quiescent, contractile cell phenotype that has been implicated in 
cardiovascular conditions including vasospasm and hypertension, any extra effort is 
worthwhile to uncover the details in the largely unknown signaling pathways and 
interactions of dVSMCs. This is understood to be a necessary prerequisite for developing 
appropriate therapeutics for cardiovascular disorders.   
Ferret as a Model Organism 
The ferret has been chosen as a model system because, both on the protein level 
as well as in the overall cardiovascular physiology, ferrets are closely related to humans 
(7, 30).  Because of this close relationship, ferret tissue generally cross-reacts with 
human-derived reagents and has been used as the model organism for the study of several 
human diseases (8, 164).  Furthermore, this lab has already developed a foundational 
background in ferrets allowing for potential integration and comparison of these studies 
to form a more complete picture. 
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FOCAL ADHESIONS 
In order for cells to survive, they must communicate with their environment.  
Connection or adhesion to the extracellular matrix (ECM) and the subsequent interactions 
play key roles in cell behavior, regulation, and fate (78, 87).  Since the ECM provides the 
local physical microenvironment, it can serve as a scaffold to guide cell anchoring, 
migration, and other morphogenic roles (75) as well as to transmit environmental signals 
to the cell that influence and impact differentiation, growth, and death (15, 76).  The sites 
of ECM adhesion with the cell are loosely grouped together under the title “focal 
adhesions” (FAs) and were initially discovered by electron microscopy in 1971 (1).  FAs 
are macromolecular protein assemblies thought to mediate stress, stretch, and tension 
signals into and out of the cell.  They are ideally situated as mechanosensors since they 
are positioned on the inner face of the plasma membrane and connect the ECM to the 
interior actin cytoskeleton which in turn mediates morphological changes.  
FAs are ubiquitous among adherent, migrating cells, but their exact protein 
composition, structure, size and distribution is widely varied (75). There are more than 
100 different proteins that have been associated with FAs (75, 157, 218) (Figure 1.6) and 
the list continues to grow.  The inherent complexity of the system and its regulation is 
further complicated by the observation that several of the major protein components of 
FAs have the potential for more than 10 different binding partners (75).  Finally, FAs are 
subject to continual remodeling.  An important example of this dynamic character is the 
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observation that the size of a FA correlates positively with the amount of force acting on 
it (6), consistent with transducing external stress, stretch, and tension signals. 
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Figure 1.6 Focal adhesion complexity.  Diagram illustrating the complexity of FA 
protein binding and signaling.  FAK and Src (red diamonds) are critical tyrosine kinases 
involved in FA regulation.  Paxillin, zyxin, Cas, talin, and vinculin (purple rectangles) 
have roles in adaptor protein/signaling function.  Beta-integrin (green rectangle) is a 
trans-membrane adhesion receptor.  Actinin, VASP, filamin (purple circles) are actin 
regulators.  Actin (white circle) is the primary cytoskeletal component.  Modified from 
Zaidel-Bar et al, 2007 (218).   
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Focal Adhesion Proteins 
Although there are a vast array of FA proteins, these studies are focused on a few 
of the more well-studied ones, anticipating that what is already known in migrating, non-
contractile cells could inform my studies of what is unknown in non-migrating, 
contractile tissue (Figure 1.7). 
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Figure 1.7 Focal adhesion structure.  Diagrammatic illustration of a few selected FA 
proteins of interest, their potential binding partners, and estimated geographical location 
within the FA.  VASP, zyxin, and actinin are thought to me more closely associated with 
actin regulation.  Vinculin, CAS, and Src occupy regions closer to the plasma membrane.  
Filamin, talin, paxillin, and FAK all potentially compete for binding to transmembrane 
integrins that are connected to the ECM.  Diagram based on compilation of data from 
several reviews and studies including Kanchanawong et al 2010, Zaidel-Bar et al 2007, 
and Mitra et al 2005 (107, 138, 218). 
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Integrins 
 Integrins are transmembrane proteins that connect the ECM to the FAs (105, 155, 
182).  One subunit consists of a heterodimer of an  and  integrin noncovalently bound 
to each other (131).  The N-termini come together to form a large head that binds to 
specific amino acid sequences of ECM proteins (collagens, fibronectin, vitronectin, 
thrombospondin, elastin, tenascin, osteopontin and several laminins) (131).  The shorter 
C-terminal intracellular tail binds to FA proteins and cytoskeletal elements (26).  Because 
they physically connect the cytoskeleton to the ECM, integrins play a critical role in two-
way mechanical force transmission as well as signal transduction (78).  It has been 
hypothesized that integrins are critical for regulating blood flow in response to vascular 
injury (47, 48).  There are 24 known integrins, 13 of which have been found in VSMCs 
although v and 1 are thought to be the most prevalent subunits (82, 139).  
FAK, Cas, Src 
Focal adhesion kinase (FAK, 125 kDa) is a critical FA tyrosine kinase consisting 
of a FERM domain (4.1 protein, ezrin, radixin, moesin), a kinase domain, and a focal 
adhesion targeting (FAT) domain (181).  The FAT domains targets FAK to FAs where it 
is autophosphorylated at Y397 upon integrin binding (138, 197).  This activates FAK and 
exposes a Src (60 kDa) homology SH2 binding site (91, 150, 179, 181).  Binding of Src 
to FAK creates a complex that allows SH3-mediated binding of p130Crk-associated 
substrate (Cas, 130 kDa) and subsequent phosphorylation (37, 127).  Activation and 
exposure of Cas domains to tyrosine phosphorylation reveals docking sites for other 
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adaptor proteins and effectors (37, 178).  FAK, Cas, and Src can then further activate, 
inactivate and regulate one another through other phosphorylation sites (101, 111, 140, 
168), ultimately controlling FA turnover (138) and downstream activation of the 
extracellular signal related kinase (ERK) pathway, which activates myosin light chain 
kinase, which is responsible for contractility (163, 181).   
Paxillin 
Paxillin (68 kDa) is an important adaptor/scaffold protein in FAs (201, 202).  It is 
known to directly bind FAK, vinculin, and Src (193, 203, 213).  Once bound, subsequent 
phosphorylations lead to the recruitment of other adaptor proteins (like Cas), thereby 
regulating FA dynamics (24, 162), and triggering other signaling cascades (such as 
mitogen activated protein kinase; MAPK) (118).  It has also recently been suggested that 
paxillin may directly bind integrins (128). 
Filamin 
Filamin (280 kDa) is a scaffolding and actin crosslinking protein that usually 
functions as a parallel homodimer.  Each monomer can bind actin and create a high-angle 
bend that supports and stabilizes orthogonal actin branching networks at FAs (67).  It also 
competes with talin for direct binding to beta-integrins (112). 
Vinculin/Metavinculin 
Vinculin (117 kDa) is a structural and signaling FA protein head, proline-rich 
neck, and tail domain (59, 104, 211).  In its inactive form, the head and tail region are 
bound to each other, thus obscuring active binding sites (5, 33, 225, 227).  When 
activated, vinculin opens up, revealing binding sites for actin on the tail and talin on the 
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head domain (219, 227).  Metavinculin (150 kDa) has a 69 amino acid insert in the tail 
domain although it is not yet clear what the functional significance of the extra piece is 
(25, 81).  Although vinculin is ubiquitously expressed, metavinculin has only been found 
in muscle and is not as well studied (64, 79, 175). 
Zyxin 
Zyxin (82 kDa) was first identified as a scaffolding protein in smooth muscle in 
1991 (44).  Since its discovery however, the majority of characterizing and functional 
studies have focused on its role as a mechanosensor in FAs of migrating fibroblasts (217) 
and a possible role in costameres (99). Recent work in cultured cells has shown that zyxin 
may be regulated by phosphorylation (31), strongly suggesting that, rather than playing a 
passive scaffolding role in FAs, it instead is subject to multiple reversible regulatory 
modifications.  Furthermore, the exertion of mechanical forces facilitates zyxin 
recruitment to FAs (97) while decreasing mechanical load increases the unbinding rate 
for zyxin at FAs (124).  Zyxin knockdown by RNAi in cultured 3T3 and HeLa cells 
results in loss of actin stress fibers and reduction of early-stage FAs (86, 93).  Finally, 
zyxin has been shown to shuttle between FAs and the nucleus (146), and has been 
implicated as a mechanosensitive modulator of gene expression (29).  Using the growing 
body of research on zyxin in migrating cells as a foundational framework to build upon, 
these studies address my prediction that the fundamental findings about zyxin in 
migrating cells will still be applicable in the functionally different dVSM phenotype. 
Vasodilator-stimulated phosphoprotein (VASP) 
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Vasodilator-stimulated phosphoprotein (VASP, 50 kDa) was first identified in 
1989 (89) and characterized in several types of tissues (158) and then suggested as a 
potential binding partner for zyxin in 1995 (159).  Since then the role of this interaction 
has been well characterized in migrating cells.  VASP binds the proline rich region of 
zyxin (50, 154) through a complicated head-tail interaction (141).  Applied mechanical 
stress induces zyxin recruitment of VASP from FAs to actin stress fibers (215).  Zyxin 
gene deletion results in reduced accumulation of VASP and deficiencies in actin stress 
fiber remodeling (98).  Notably, zyxin colocalizes at FAs and along stress fibers but is 
not present with VASP at lamellipodia (172). VASP may be recruited to the lamellipodia 
by interacting with the polyproline sequence in vinculin (77). 
In migrating cells, VASP has been implicated as a regulator of actin incorporation at 
barbed ends of actin filaments (13, 18, 26) at the leading edge tips of lamellipodia, 
filopodia, and stress fibers (72, 77, 158, 171, 192).  VASP has been shown to promote 
actin polymerization (9, 12) and directly accelerate actin elongation (21, 152).  It also 
works indirectly by recruiting profilin, a known actin polymerization promoter (65, 108).  
In dVSMCs, VASP is targeted to dense bodies and plaques and is necessary for actin 
polymerization (115).  Even though dense plaque structure and function is somewhat 
different than in cultured, migrating cells, the known similarities between the role of 
VASP in differentiated and non-differentiated cells (26, 115) suggest there may be more 
crossover between cell types.  Since VASP’s actin polymerization role is conserved, and 
the VASP-zyxin interaction in migrating cells is critical for proper actin formation, it 
seems likely that a VASP-zyxin interaction exists in dVSMCs. 
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Alpha-actinin 
Alpha-actinin (107 kDa) is an actin cross-linking protein that is part of the 
spectrin family (that includes dystrophin) (49, 60, 185).  The two non-muscle isoforms 
are generally associated with FAs (17, 38, 58) and have been shown to recruit and bind 
zyxin (45, 126, 160).  Less is known about the non-motile muscle isoforms, but it is 
thought that they may be predominantly associated with the non-contractile actin (63). 
Actin 
In dVSMCs, actin (42 kDa) makes up about 20% of the overall protein (114) and 
can be roughly divided into two categories: contractile actin that interacts with myosin to 
enable cell shortening and non-muscle actin that does not interact with myosin (214).  
This thesis will focus primarily on contractile actin and its interaction with and regulation 
by proteins associated with FAs (particularly VASP and zyxin). 
Actin cytoskeleton remodeling is important for a wide range of cellular functions 
including migration, axon guidance, motility, contraction, and lamellipodia formation 
(35, 114, 117, 156, 199).  Actin polymerization is regulated by multiple pathways 
including decreased depolymerization, increased new filament branching, and increased 
or accelerated elongation of existing filaments (121, 156, 224).  Recent studies have 
shown that, while not as fast or extensive as in migrating cells, actin cytoskeleton 
remodeling occurs in dVSMCs (114) and regulates diameter, compliance, and contractile 
force (68, 69, 134).  This can occur at any site in the cell with barbed actin filaments, 
which, in smooth muscle, includes membrane-localized FAs.   
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Focal Adhesion Dynamics in Migrating Cells 
 Actin polymerization at the leading edge of a migrating cell typically produces 
protrusions in the direction of movement.  Integrins in the cell bind to ECM proteins (like 
collagen and elastin), clustering together and recruiting early FA proteins like talin and 
vinculin (216).  This early stage FA, sometimes referred to as a “focal complex” can 
either mature into a fully formed FA or disappear.  Maturation involves recruitment of 
cytoskeletal and cytoplasmic proteins for both signaling and structural integrity.  FA 
growth is tension dependent and its composition and size are constantly regulated by 
tyrosine phosphorylations of constituent signaling proteins (73, 217).  As the cell moves 
forward, these mature FAs help the cell adhere to the ECM.  Eventually, FAs detach and 
the protein components are broken down (14, 120).  This process is shown in Figure 1.8. 
 It should be noted that most studies of FA mechanics and behavior have been 
performed on two-dimensional substrates.  FA behavior, although similar in general, 
changes markedly when cells are placed in a three-dimensional environment (46).  This 
again highlights how important it is to study FA dynamics in dVSMCs.  Although I 
expect similarities, FA mechanics in an intact three-dimensional (3-D) tissue 
environment in non-migratory cells are almost certain to be significantly different from 
what is observed in cultured, migratory cells. 
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Figure 1.8 Focal adhesion dynamics.  Illustration of the life cycle of FAs in migrating 
cells.  New focal adhesions form at the leading edge of a migrating cell.  They grow and 
mature into fibrillar adhesions by recruiting more proteins through kinase signaling.  As 
the cell moves over the FA, the FA travels to trailing edge of the cell where it is 
disassembled and the proteins broken down for eventual reuse at new FAs at the leading 
edge.  Modified from Broussard et al, 2008 (22). 
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Focal Adhesion Dynamics in Non-Migratory Cells 
Dynamic remodeling of FAs and the associated actin cytoskeleton is known to be 
critical for cell function in proliferative and migratory cells. FA formation at the leading 
edge, gradual maturation, and eventual turnover have been extensively studied (16, 22, 
212). However, the degree to which FAs in non-migratory, fully differentiated cellular 
phenotypes are dynamic, and the functions of those FAs embedded in tissue, have yet to 
be fully clarified. 
Recent studies in our lab and elsewhere have demonstrated that the actin 
cytoskeleton in non-migrating, contractile VSM is not a totally static structure (For 
reviews, see (88, 113, 209, 214)). In fully dVSMCs, actin polymerization increases in 
response to the vasoconstrictor phenylephrine (PE) (114). Furthermore, it has been shown 
that the actin elongation factor, VASP (vasodilator-stimulated phosphoprotein), is 
necessary for alpha-agonist induced actin polymerization in VSM (115). Interestingly, in 
airway smooth muscle, Neural Wiskott-Aldrich Syndrome protein (N-WASP) activation 
of the Actin-related protein (Arp) 2/3 complex has been shown to be necessary for actin 
polymerization and acetylcholine-induced contractility (224). However, the functional 
specifics of how cytoskeletal remodeling is involved in the VSM contractile response 
remain unclear. 
Likewise, evidence exists that FAs in VSM may not be purely structural, fixed 
elements. In airway smooth muscle, agonist-induced vinculin (102), paxillin (195), FAK, 
talin (148), and alpha-actinin (223) redistribution occurs and are necessary for active 
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tension development with cholinergic agonists. In dVSM, VASP shifts from the soluble 
fraction to the insoluble fraction in response to a phorbol ester (115), and Src and CAS 
redistribute between insoluble and soluble fractions in response to an alpha-agonist (136). 
Finally, noradrenaline or endothelin-induced stimulation of small mesenteric arteries 
causes redistribution of paxillin from a soluble fraction to an insoluble fraction (147). 
Beyond this work, it is unclear whether other FA proteins in dVSM remodel in response 
to contractile stimuli. Furthermore, the degree of movement, the mechanism, and the 
precise targets are largely unknown (167). 
 
ENDOSOMES 
 Endocytosis, a process by which cells use the plasma membrane to engulf 
extracellular fluids or particles, is used to acquire and transport nutrients (189).   This 
involves three steps: invagination and pinching off of the plasma membrane, 
transportation of the vesicles, targeting and tethering to final destination (132). 
Endocytosis can be divided into phagocytosis (uptake of particles) and pinocytosis 
(update of fluids).  Pinocytosis can be further divided into macropinocytosis [membrane 
patches > 1 m (116)], clathrin-mediated endocytosis, caveolae-mediated endocytosis, 
and clathrin- and caveolae-independent endocytosis (41, 144). 
 After an internalization (which is assisted by barbed end actin growth to 
physically pinch off the vesicle (40, 106, 188), endosomes travel along existing actin 
(short-range) or microtubule (long-range) tracks.  Movement is facilitated by either 
myosin, dynein, or kinesin motors (3, 130).  Regulation and targeting is accomplished by 
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various adaptor complexes and a range of Rab GTPases (monomeric G-proteins that 
regulate membrane traffic through active or inactive GTP or GDP-bound forms 
respectively) (74, 142, 170, 198, 221).  Generally speaking, vesicles are first sent to the 
early endosome/sorting endosome where cargo fate is decided.  Proteins can either return 
to the plasma membrane via recycling endosomes or go on to the late endosome.  From 
there, they go to either the trans-Golgi network or lysosome for degradation (85, 189) 
(Figure 1.9). 
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Figure 1.9 Endocytic pathways.  Simplified diagram of the various endosome pathways, 
the molecular motors involved, and a few of the accessory proteins of interest.  Dynamin 
constriction and actin filament elongation actively facilitate vesicle budding off of the 
plasma membrane.  Vesicles travel along microtubule or actin networks to fuse with 
early/sorting endosomes.  From there, proteins can be directed to the late endosome and 
eventually the lysosome or trans-golgi network, or be recycled back to the plasma 
membrane through the recycling endosome.  All of these processes are regulated and 
modulated by various adaptor and motor proteins, particularly specific Rab GTPases.  
Based on reviews by Soldati and Schliwa 2006 and Grant and Donaldson 2009 (85, 189). 
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It is known that endocytic pathways mediate FA protein recycling in migrating, 
proliferating cells. This has been studied most thoroughly in the case of the FA regulator 
c-Src (109, 110, 176, 200). Endocytic recycling of transmembrane integrins and its affect 
on FA regulation is also well studied (4, 28, 32, 61).  Some recent studies have implicated 
endocytic recycling in shuttling of membrane-associated proteins in cultured myocytes 
(96, 133).  However, endocytic recycling of FA proteins in the dVSMC phenotype has 
not been examined, to the best of my knowledge. At first glance, endosomal traffic is 
expected to be minimal in non-synthetic cell types such as dVSMCs, but no alternate 
mechanism has been suggested for FA protein translocation in these cells. 
 
THESIS RATIONALE/AIMS OF THIS THESIS 
Although dVSMCs are known to be critical in the progression and pathogenesis 
of cardiovascular disease, much of the mechanisms and regulation of contractile activity 
remains unclear.  In cultured, migrating fibroblasts, FAs play an essential role in cellular 
development, migration, and proliferation. Although, FAs exist in dVSMCs, since this 
cell phenotype is non-migratory, I wanted to know in what way focal adhesions in dVSM 
are similar to and different from FAs in migrating cells.  Understanding the role of FAs in 
dVSM could better inform our understanding of cardiovascular disease and present 
therapeutic targets for the treatment of disease.   
This thesis tests the hypothesis that FA proteins in dVSMCs dynamically 
redistribute in response to an alpha-agonist and that this redistribution is dependent on 
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microtubule and actin-reliant endocytic recycling.  In chapter 3 the data show that, like 
their migrating counterparts, FA proteins exist in dVSMCs and are concentrated in 
regularly distributed punctate points.  In chapter 4 experiments are performed that 
quantify the stimulus-induced distribution and re-distribution of several major FA 
proteins in dVSM. I show that some, but not all, FA proteins are mobile.  This finding is 
in contrast to the behavior of FA proteins in migrating fibroblasts which undergo 
turnover and complete breakdown as they move from the leading edge to the trailing edge 
of the moving cell. 
Chapter 5 presents evidence that inhibiting endocytic recycling prevents agonist-
induced redistribution.  This is accomplished either by inhibiting budding, or ablation of 
microtubule or actin networks necessary for endosome movement.  Additional 
experiments show increased proximity of FA proteins to endocytic markers after 
stimulation.  Finally, I demonstrate that endocytic components are important contributors 
in determining the strength and speed of VSM tissue contraction. 
These novel findings open up new possibilities for research and targeted drug 
therapies.  Showing how important FA proteins and endocytic recycling are for 
contractile response will hopefully encourage future research into these areas and shed 
light on potential targets to alleviate developing cardiovascular disease. 
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CHAPTER 2: MATERIALS AND METHODS 
 
MATERIALS 
Enzymes and Chemicals 
Isoflurane purchased from VEDCO (St. Joseph, MO).  Adenosine 5’-triphosphate 
disodium salt (ATP), colchicine, Cytocholasin D, 12-deoxyphorbol 13-isobutyrate 20-
acetate (DPBA), N-ethylmaleimide (NEM), primaquine bisphosphate, Sigmacote, Triton 
X-100, and Trypsin Inhibitor purchased from Sigma-Aldrich (St. Louis, MO).  Bovine 
Serum Albumin (BSA) Fraction V was purchased from gibco by Life Technologies 
(Grand Island, NY).  Collagenase Type 2 was purchased from Worthington Biochemical 
Corporation (Lakewood, NJ).  Elastase Grade II lyophilizate purchased from Roche 
Diagnostics (Indianapolis, IN).  Coomassie Brilliant Blue G-250 purchased from Thermo 
Scientific (Rockford, IL).  Donkey and goat blocking serum purchased from Vector 
Laboratories (Burlingame, CA).  Tween-20 and tetramethylethylenediamine (TEMED) 
purchased from Biorad (Hercules, CA).  FluorSave and Insolution protein phosphatase 2 
(PP2) purchased from Calbiochem (San Diego, CA).  FM4-64FX membrane stain and all 
Alexa-Fluor secondary antibodies purchased from Invitrogen (Eugene, OR).  Latrunculin 
B purchased from A. G. Scientific Inc. (San Diego, CA). 
Unless otherwise stated, lab chemicals were purchased from Fisher Scientific 
(Fair Lawn, NJ). 
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Antibodies  
Antibodies directed against GAPDH (rabbit, 1:2000) and vinculin (mouse, 
1:4000) were from Sigma-Aldrich (St. Louis, MO); Rab5 (mouse, 1:500), paxillin 
(mouse, 1:500), CAS (mouse, 1:500), and EEA1 (mouse, 1:500) were from BD 
Transduction Laboratories (San Jose, CA); zyxin (goat, 1:1000), Src (rabbit, 1:500), and 
FAK (rabbit, 1:100) were from Santa Cruz Biotechnology (Santa Cruz, CA); alpha-
actinin (rabbit, 1:1000) was from Abcam (Cambridge, MA); pan-actin (rabbit, 1:2000) 
was from Cytoskeleton Inc. (Denver, CO); VASP (rabbit, 1:1000), phospho-paxillin 
(1:500), and phospho-myosin light chain (1:1000) were from Cell Signaling Technology 
(Danvers, MA); and Filamin (mouse, 1:500) and beta-integrin (rabbit, 1:500) were from 
Millipore (Billerica, MA). 
 
METHODS 
Coomassie Gel Stain for Total Protein 
Gel was placed in a Coomassie blue staining solution (25% isopropanol, 10% acetic 
acid, 0.1% Coomassie) for one hour while covered and rocking at slow speed.  The 
staining solution was then replaced with a destaining solution consisting of 10% 
isopropanol and 10% acetic acid and set on a rocker for 20 minutes.  The destaining 
solution was replaced with fresh destaining solution every 20 minutes for 5 cycles.  The 
gel was then left in destaining solution overnight and washed with distilled water 2 times 
before being scanned and analyzed in the same manner as a western blot (see below). 
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Lowry Protein Assay 
Lowry kit was purchased from Biorad (Hercules, CA).  All Lowry measurements 
were done in duplicate.  A calibration curve was created with 0, 3, 7.5, 15, 22.5, and 30 
g of BSA per 1.5 mL microcentrifuge tubes added to 3 L of the buffer the samples 
were stored in.  Enough ddH2O was then added to each tube to bring the final volume to 
30 L.  Three L of each test sample was added to tubes with 27 L ddH2O. Solution B 
(1.2 mLs per well) was prepared in a 24 well plate.  One hundred fifty L of a Solution A 
and Solution S mixture (50:1 ratio, respectively) were added to each sample, mixed and 
then, the now 180 L, was transferred to the wells with Solution B.  The mixtures in the 
wells were immediately mixed and incubated for 15 minutes at room temperature (the 
A/S mixture gets cloudy if allowed to sit too long).  UV-Vis Spectrophotometer 
(Shimadzu, Kyoto, Japan) readings were taking at 750 nm.  Sample protein concentration 
estimates were made based on the BSA calibration curve. 
Western Blot 
SDS PAGE gel electrophoresis: the night before the experiment, a 10% 
separating/resolving gel was poured into a Biorad apparatus (Hercules, CA) (2.89 mL 
ddH2O, 187.5 L glycerol, 1.875 mL lower Tris buffer (36.33 g Tris, 0.4% SDS, ddH2O 
to 200 mL, pH=8.8), 2.5 mL of a 30% acrylamide/0.8% bis-acrylamide weight/volume 
solution (National Diagnostics, Atlanta, GA), 75 L of a 10% ammonium persulfate 
(APS) solution, 7.5 L N,N,N',N'-tetramethylethylenediamine (TEMED)).  APS and 
TEMED were added and mixed just before pouring.  Gels were covered with a thin layer 
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of ddH2O to even out the gel and prevent drying.  The following day, the ddH2O was 
removed and the stacking gel with combs inserted was poured (4.0 mL ddH2O, 1.565 mL 
upper Tris buffer (12.11 g Tris, 0.4% SDS, ddH2O to 200 mL, pH 6.8), 625 L of a 30% 
acrylamide/1.6% bis-acrylamide solution, 62.5 L APS, 6.25 L TEMED) and allowed 
to polymerize.  During this time, frozen tissue homogenates were slowly thawed on ice.  
Small amounts of each sample were combined with 1x sample buffer (8% SDS, 40% 
glycerol, 0.25 M Tris (pH=6.8), 10% -mercaptoethanol, 0.01% bromophenol blue), 
boiled for 6 minutes, and 5 L of 10 mM N-Ethylmaleimide (NEM) was added to each 
sample.  Combs were removed from gels and gels were placed into running apparatus 
filled and surrounded by 1X running buffer (25mM Tris, 0.192 M glycine, 0.1% SDS).  
Samples were loaded into the gel with a marker lane using Precision Plus Protein Dual 
Color Standards (Biorad, Hercules, CA).  The gel was then run at constant current (10-15 
mA) on a GE Healthcare Biosciences Electrophoresis Power Supply (Pittsburgh, PA) 
until the samples entered the separating gel.  The current was then increased to between 
20 and 25 mA until the samples reached the bottom of the gel. 
The gel was then carefully removed and added to a “sandwich” for transfer.  From 
the bottom up, there were two sheets of blotting paper (VWR International, West Chester, 
PA) pre-soaked in Anode I buffer (0.3 M Tris, 10% methanol), one sheet of blotting 
paper soaked in Anode II buffer (25 mM Tris, 10% methanol), activated membrane 
(Millipore Immobilon-FL transfer membrane (Billerica, MA) soaked in methanol and 
rinsed with ddH2O), gel, and two sheets of blotting paper soaked in Cathode buffer (25 
mM Tris base, 40mM glycine, 10% methanol).  The whole sandwich was placed on the 
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Hoefer SemiPhor semi-dry transfer unit (Amersham Pharmacia Biotech AB, San 
Francisco, CA) and run at 120 mA (per gel) constant current for 90 minutes. 
At the end of this time, the membrane was carefully removed, trimmed and placed 
in Odyssey Infrared Imaging System Blocking Buffer (LI-COR Biosciences, Lincoln, 
NE) while rocking for one hour.  The membrane was then incubated with primary 
antibodies in Tris buffer saline with Tween (TBST) (18g NaCl, 2.424 g Tris, ddH2O to 
1L, pH 7.4, 1 mL Tween-20, pH=7.4) overnight at 4C.  The following day, the 
membrane was rinsed 4x for 5 minutes each in TBST, and incubated while rocking and 
protected from light in LI-COR secondary antibodies diluted 1:000 in TBST.  Following 
6 rinses, 5 minutes each in TBST, immunostained membranes were imaged with an 
Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln NE), allowing 
simultaneous imaging of two separate color channels. Quantitative densitometric analysis 
was performed with Odyssey software (V. 3.0.16) by comparing band intensity 
summations after consistent background subtraction. 
Contractility Measurements in Serum-Free Organ Culture 
All procedures in this study were performed in accordance with and after approval 
from the Boston University Institutional Care and Use Committee. Male sable ferrets 
(Mustela putorius furo) from Marshall Farms, North Rose, NY, were euthanized with an 
inhalant overdose of 15 mL of isoflurane. The thoracic segment of the aorta was quickly 
excised and placed in an ice-cold oxygenated physiological Krebs salt solution (PSS) 
consisting of 120 mmol/L NaCl, 5.9 mmol/L KCl, 1.2 mmol/L NaH2PO4, 25 mmol/L 
NaHCO3, 11.5 mmol/L dextrose, 1 mmol/L CaCl2, and 1.4 mmol/L MgCl2. The tissue 
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was then dissected in the oxygenated (95% O2, 5% CO2) PSS solution at room 
temperature to remove fat, connective tissue, and endothelium. Aortic rings 4 mm in 
length were attached to force-displacement transducers (Grass Instrument Co FT03, 
Quincy, MA) in a 37C PSS Myobath organ bath (World Precision Instruments, Sarasota, 
FL) and allowed to equilibrate for one hour after being stretched to 2g passive resistance. 
The rings were then stimulated with a 51 mmol/L KCl PSS in which 51mmol/L NaCl 
was replaced with 51mmol/L KCl to test for viability. After 10 minutes, the tissue was 
washed three times with PSS and allowed to relax for one hour before experimentation 
began. Force read outs and data were analyzed using LabChart 7 v7.3.3 software 
(ADInstruments, Colorado Springs, CO). At the end of the experiment, tissue rings were 
quick-frozen by immersion in an acetone/dry ice slurry containing 10 mmol/L 
dithiothreitol (DTT) and placed in -80C degree freezer in preparation for further 
processing. 
Cell Isolation 
Single dVSMCs were enzymatically dissociated from ferret aorta tissue according 
to a previously published method (114, 115). One liter of a Hanks physiological salt 
solution was prepared fresh the morning of experimentation consisting of 137 mmol/L 
NaCl, 5.4 mmol/L KCl, 0.42 mmol/L NaH2PO4, 0.44 mmol/L KH2PO4, 4.17 mmol/L 
NaHCO3, 10 mmol/L Hepes, 5.55 mmol/L glucose, pH=7.4.  An appropriate amount was 
combined with BSA and sucrose for a total volume of 100 mL of a 0.2% BSA and 300 
mM sucrose solution.  This solution was then combined with collagenase (12 mg of 360 
U/mg activity with 4.14 mL of Hanks/BSA/sucrose), elastase (11.5 mg of 4.10 U/mg 
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activity with 4.00 mL of Hanks/BSA/sucrose), and trypsin inhibitor (5 mg/mL) into three 
different aliquots labeled T1, T2, and T3 (Table 2.1). 
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 T1 T2 T3 
Collagenase 1.38mL 1.38mL 1.38mL  
Elastase 1.33mL 0.67mL 0.67mL 
Trypsin Inhibitor 50 L 50 L 50 L 
Hanks/BSA/Suc 4.79mL 5.45mL 5.45mL 
Tot Volume 7.5 mL 7.5 mL 7.5 mL 
Table 2.1.  Cell isolation enzyme solutions.  Quantities and contents of three different 
enzymatic time point solutions for single cell isolation.  Equal final volumes with 
differing amounts of elastase are used for the three different enzymatic incubations. 
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Male sable ferrets (Mustela putorius furo) from Marshall Farms, North Rose, NY, 
were euthanized with an inhalant overdose of 15 mL of isoflurane. The abdominal 
segment of the ferret aorta was quickly excised and placed in an ice-cold oxygenated 
physiological Krebs salt solution (PSS) consisting of 120 mmol/L NaCl, 5.9 mmol/L 
KCl, 1.2 mmol/L NaH2PO4, 25 mmol/L NaHCO3, 11.5 mmol/L dextrose, 1 mmol/L 
CaCl2, and 1.4 mmol/L MgCl2. The tissue was then dissected in the oxygenated (95% O2, 
5% CO2) PSS solution at room temperature to remove fat, connective tissue, and 
endothelium.  The strip was cut down to a length of 3.5 cm (approximately 150 mg).  One 
longitudinal cut was made down the length of the strip and the tissue was unfolded, 
flattened, and pinned.  Using small, circular motions, the endothelium was lightly 
brushed off with a rubber policeman.  The strip was then cut horizontally into 11-12 
pieces.  Each of those pieces was cut into thirds in the opposite direction for a total of 
about 35 pieces.  All pieces were then gently transferred to an oxygenated, pre-
siliconized 125 mL flask that included T1.  The flask was then stoppered with oxygen 
line still inside and placed in 34C Magni Whirl constant temperature water bath (Blue M 
Electric a unit of General Signal, Watertown, WI) and set to shake back and forth 60 
times per minute. 
Flasks were siliconized by pouring 25 mL of Sigmacote back and forth between 2 
flasks while slowly rotating the flasks for 20 minutes.  The flasks were then dried 
overnight, baked for 1 hour at 110 F, soaked in ddH2O overnight, and then left to air dry 
for several days. 
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After 80 minutes of shaking, the T1 solution with the tissue strips was carefully 
poured through a mesh square (mesh opening 500 m, % open area 39, thickness 610 
m) (Spectrum Laboratories, Inc., Rancho Dominguez, CA) into another siliconized 125 
mL flask while rinsing with 10 mL Hanks/BSA/Suc.  The mesh square was then flipped 
over on top of original flask and T2 solution was emptied onto it, to wash the tissue back 
into flask.  This was then put back in shaking water bath after plugging with an oxygen 
line fed inside.  The T1 solution with cells was evenly distributed amongst the wells of a 
6 well flat bottom plate with low evaporation lid (Becton Dickinson Labware, Franklin 
Lakes, NJ) with 22 x 22 mm glass coverslips (VWR International, West Chester, PA) 
lying on the bottom of the wells and placed on ice in a closed container while 
oxygenated.  Coverslips were pre-etched by shaking in a 2N NaOH solution for 2 hours 
before rinsing several times with ddH2O.  This was repeated for T2 and T3 after 
incubations of 30 min and 20 min respectively.  The plates with the cell solution were 
then allowed to sit on ice for one hour to give the cells time to adhere to the coverslips. 
Optional Pre-Permeabilization 
At this point, there was an optional pre-permeablization step before fixation.  Cells were 
incubated for one minute at room temperature in a cytoskeletal stabilization buffer (50 
mM NaCl, 3 mM MgCl2, 10 mM PIPES, 2 mM EGTA, 30 mM Sucrose, pH 6.8) with 
0.1% Triton-X. 
After examining one coverslip from each of the different time points under bright 
field 4x magnification on a Nikon Diaphot microscope, the batch with the highest quality 
(length and shape) and quantity of cells was selected for further processing.  The 
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remaining coverslips from the selected batch were transferred to new 6 well plates at 
room temperature and covered with a 4% paraformaldehyde solution for 10 minutes. 
 Two grams of paraformaldehyde were mixed with 5 mL ddH2O and heated to 
60C while stirring. Fourteen drops of 1N NaOH solution were added until the entire 
solution cleared.  This was then added to 45 mL of a 0.1M sodium phosphate buffer 
(10.374 g Na2HPO4, 1.559 g NaH2PO4, 500 mL ddH2O).  An additional 0.1 g of NaCl 
was added and the pH was adjusted to 7.4 if necessary. 
After 10 minutes, the paraformaldehyde was aspirated and replaced with 2 mL of 
a 0.1mM glycine in 1% BSA Hanks PSS solution per well.  After 5 minutes, the glycine 
solution was aspirated out and replaced with fresh glycine.  After another 5 minutes this 
solution was replaced with 0.1% Triton X-100 in 1% BSA Hanks PSS and the cells were 
placed on a slow rocking platform for 10 minutes (VWR International, West Chester, 
PA). 
Cells were then washed 3 times for 5 minutes each in 0.05% Triton X-100 in 1% 
BSA Hanks PSS before being placed in a 0.05% Triton X-100, 1% BSA Hanks PSS with 
10% blocking serum and gently rocked for one hour.  Coverslips were then incubated 
overnight at 4C with primary antibodies and 2% blocking serum, 0.05% Triton X-100, 
and 1% BSA Hanks PSS. 
The following day, all coverslips were washed 3-6 times for 10 minutes each time 
in 0.05% Triton X-100 1% BSA Hanks PSS.  They were then incubated in the dark for 30 
minutes with secondary antibodies in Hanks PSS (1:500).  All secondaries were Alexa-
Fluor secondaries from Invitrogen (Eugene, OR).  After three more 5 minute washes in 
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Hanks PSS, the coverslips were dipped in ddH2O and carefully affixed to slides with 
FluorSave Reagent (Calbiochem, Darmstadt, Germany).  This whole process is 
summarized in Table 2.2. 
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Length 
(minutes) Solution 
10 4% paraformaldehyde 
5 0.1 mM glycine in 1%Bsa Hanks PSS 
5 0.1 mM glycine in 1%Bsa Hanks PSS 
10 0.1% Triton X-100 in 1%Bsa Hanks PSS  
5 0.05%Triton X-100 in 1%Bsa Hanks PSS  
5 0.05%Triton X-100 in 1%Bsa Hanks PSS  
5 0.05%Triton X-100 in 1%Bsa Hanks PSS  
60 10% Block Serum + 0.05%Triton X-100 in 1%Bsa Hanks PSS  
Overnight 
1' antibody + 2 % goat serum +0.05%Triton X-100 in 1%Bsa 
Hanks PSS   
10 0.05%Triton X-100 in 1%Bsa Hanks PSS  
10 0.05%Triton X-100 in 1%Bsa Hanks PSS  
10 0.05%Triton X-100 in 1%Bsa Hanks PSS  
30 Secondary fluorescent conjugated antibody in Hanks PSS no Bsa 
5 Hanks PSS  
5 Hanks PSS  
5 Hanks PSS  
Table 2.2 Cell staining protocol.  Summary of the steps and time lengths involved in 
fixing and staining single cells in preparation for microscopic analysis.  
Paraformaldehyde fixation is followed by glycine quenching, detergent permeabilization, 
blocking, primary antibody incubation, fluorescent secondary antibody incubation, and 
finally coverslip mounting. 
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Immunofluorescent Imaging in Mammalian Cells 
Deconvolution Microscopy 
For deconvolution microscopy, 3-D image stacks were acquired with a Nikon 
Eclipse TE 2000-E inverted microscope equipped with a Nikon Plan Apochromat 60XA 
(NA 1.4) oil immersion objective. Images were recorded by a high-resolution 
fluorescence CCD camera (CoolSNAPTM HQ2, Photometrics®) with NIS-Elements 
Advanced Research (Nikon) software. Out-of-focus fluorescent blur was removed by 
deconvolution of Z-stacks (Richardson-Lucy algorithm, constrained iterative-maximum 
likelihood estimation algorithm) as previously described (115). For dual labeling 
experiments, no detectable cross talk was confirmed by exchanging excitation/emission 
filters on single labeled coverslips. 
Quantitative Colocalization 
Cells that were >50 m long and > 4 m wide (enough to resolve individual FA 
structures) were selected for analysis. Thresholding was set to optimize the resolution of 
the labeled structures on visual display. Using NIS-Elements Advanced Research (Nikon) 
software, quantification of overlapping pixels by a logical ‘AND’ calculation was applied 
to a center section, excluding the nucleus and the ends of the cell. The percentage of co-
localized pixels versus the total number of pixels labeled was calculated and reported as 
percent colocalization. At least three different animals were used for each condition. 
Proximity Ligation Assay 
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Steps for PLA were identical to aortic cell isolation through overnight incubation 
with primary antibodies.  Cells were then washed 3 times for 5 minutes each time in 
Hanks PSS + 1% BSA + 0.05 % TX-100 in six well plates.  The coverslips were then 
incubated for 2 hours in PLUS and MINUS Duolink PLA probes (e.g. mouse PLUS and 
goat MINUS) (Olink Biosciences, Uppsala, Sweden) (186), diluted 1:5 in antibody 
dilution buffer (Hanks + 1% BSA + 0.05 % TX-100) (30 L buffer, 10 L PLUS probe, 
10 L MINUS probe per cover slip). 
 To conserve PLA probes, 50 L of solution was used per square coverslip.  The 
solution was first placed on a Parafilm sheet that was stretched on the inside of the lid of 
a six well plate and then each coverslip was carefully lowered onto the droplet with cell 
side down, facing the solution (this small volume and Parafilm method was also used for 
the ligation and detection steps that follow).  To protect from evaporative drying, another 
six well cover was placed on top of the cover with the Parafilm to function as a lid and 
the two together were rocked slowly at room temperature. 
After 2 hours, the coverslips were rinsed 3 times for 5 minutes each in Hanks PSS 
+ 1% BSA + 0.05% TX-100 in a six well plate.  The ligation buffer was warmed to room 
temperature ahead of time to dissolve precipitates, then diluted 1:5 in water.  Ligase was 
added (1:40) right before use. Coverslips were incubated on the ligation droplets for 30 
min at 37C.  They were then washed at room temperature 2x 2 minutes in Hanks-Tween 
(0.05%) in six well plate. 
Detection buffer was thawed then diluted 1:5 in water.  Polymerase was added 
right before use (1:80). Coverslips were incubated on 50 L detection droplets for 90-120 
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minutes at 37C.  During this time coverslips were rocked gently by hand every 20 
minutes.  To protect against evaporation, the six well plate cover and lid were wrapped in 
Parafilm to seal the edges.  Coverslips were protected from light from now through 
mounting.  After the detection incubation, coverslips were washed 2 times for 10 minutes 
each in Hanks PSS and once in ddH2O before mounting on slides with FluorSave. 
The resulting red fluorescent PLA dots were counted using NIS Elements AR 
2.30 software (Nikon, Melville, NY), and images were processed with Photoshop CS3 
software (Adobe Systems, Mountain View, CA) as previously described (208). 
Differential Centrifugation 
Ferret Tissue 
The method used here is similar to that of Kim et al 2010 (115) but has been 
modified to result in 3 rather than 2 fractions.  One sample of quick-frozen ferret tissue 
was pulverized with pre-cooled mortar and pestle in liquid nitrogen.  The ground tissue 
pieces were transferred, by careful scraping, to a glass homogenization tube on ice 
containing 0.22 mL buffer I (Tris-HCl 20 mmol/L pH 7.5, NaCl 50 mmol/L, sucrose 250 
mmol/L, DTT 10 mmol/L, EGTA 3 mmol/L, MgCl2 5 mmol/L, ATP 1 mmol/L, and 15 
L protease inhibitor cocktail).  Protease inhibitor cocktail consisted of 0.11mM 
leupeptin, 0.11mM pepstatin A, 40mM Na3VO4, 20mM NaF, 0.4mM AEBSF, and 0.4 
mM aprotinin.  This was immediately homogenized by hand for 30 seconds, avoiding up 
and down motions.  The homogenization tube was then put into a 600 mL glass beaker 
packed with a slurry of ice and water and mechanically homogenized using three bursts 
of 18 seconds set at the lowest possible constant speed on a Glas-Col Variable speed 
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homogenizer (Terre Haute, IN).  There was a 2 minute cool down period between bursts.  
The ground up tissue solution was transferred to a 1.5 mL ultracentrifugation polyallomer 
tube on ice (Beckman, Palo Alto, CA).  This process was repeated for any other 
remaining tissue samples.  
Tubes were then evenly balanced in a pre-chilled rotor and placed in a Beckman 
Coulter Optima TLX Ultracentrifuge (Fullerton, CA).  Samples were spun at 4C at 
100,000xg for 1 hour.  The supernatant was collected as the cytosolic (C) fraction. The 
remaining pellet was resuspended in 0.22 mL buffer II (Tris-HCl 20 mmol/L pH 7.5, 
sucrose 250 mmol/L, Triton X-100 0.5%, DTT 10 mmol/L, EGTA 3 mmol/L, MgCl2 5 
mmol/L, ATP 1 mmol/L, and protease inhibitors), extracted at 4C for 1 hour, and 
centrifuged at 100,000xg for 1 hour. This supernatant was collected as the Triton X-
soluble or membrane (M) fraction. The pellet was resuspended in 0.22 mL buffer III 
(Tris-HCl 20 mmol/L pH 7.5, sucrose 250 mmol/L, Triton X-100 0.5%, sodium dodecyl 
sulfate (SDS) 1.2%, DTT 10 mmol/L, EGTA 3 mmol/L, MgCl2 5 mmol/L, ATP 1 
mmol/L, and protease inhibitors), extracted at 4C for 1 hour, and spun down on a table 
top microfuge (6 minutes at 13,000 RPM) to remove nuclei and unbroken cells. This final 
supernatant was collected as the Triton X-insoluble or cytoskeletal (SK) fraction.  It 
should be noted that this method differs from the method previously used by our lab to 
monitor actin polymerization (114), most notably in the temperature used, since actin 
polymerization is optimal at 37C but, here, as is generally done, the centrifugations were 
performed at 4C to minimize any potential degradation or post-translational 
modifications of the proteins during processing. 
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Statistical Analysis 
Data are expressed as mean +/- standard error (SE) in all graphs. Significance of 
difference between two individual sets of data was evaluated by a two-tailed, paired 
Student’s t-test (significant differences reported at p < 0.05), unless indicated otherwise. 
At least 3 separate ferrets were used for all experiments. 
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CHAPTER 3: FOCAL ADHESION PROTEIN LOCALIZATION 
 
INTRODUCTION 
 FAs and the regulatory and functional role of the individual protein constituents 
has recently become an intense area of research (76, 107, 153).  Although the literature is 
not quite as extensive, Dr. Susan Gunst and colleagues have made strides in 
understanding the role of FA proteins in airway smooth muscle (102, 148, 194, 223).  
Our lab has recently had success in demonstrating the dynamic nature of the cytoskeleton 
in VSM (114, 115).  Furthermore, it was shown that the actin elongation factor, VASP, is 
localized adjacent to FA markers alpha-actinin and vinculin (Figure 3.1).  To further 
pursue the possibility that FAs in dVSMCs may remodel in response to stimuli, I 
attempted to visualize FA protein localization in dVSMCs. 
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Figure 3.1 VASP is localized adjacent to vinculin and alpha-actinin at FA-like 
structures.  Enzymatically dissociated dVSMCs were costained for alpha-actinin and 
VASP or vinculin and VASP.  Deconvolved, merged, center sections of cells were used 
for analysis.  (A) alpha-actinin (green top).  (D) vinculin (green bottom).  (B,E) VASP 
(red) (C,F) merged.  White arrows indicate spots where vinculin and VASP colocalize. 
Scale bar 10 m.  Modified from Kim et al, 2010 (115). 
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IMMUNOFLUORESCENT IMAGING OF INDIVIDUAL PROTEINS 
Zyxin 
I then extended these experiments to zyxin, a known binding partner of VASP in 
migrating cells (50, 159).  Because of zyxin’s binding to and targeting of VASP (98), 
immunofluorescent imaging was expected to show staining patterns similar to that of 
VASP (115).  Both portal vein and aortic cells were enzymatically dissociated, isolated, 
fixed and stained for zyxin (Figure 3.2).  Immunofluorescent images showed low levels 
of cytosolic background signal interspersed with a regular distribution of bright punctate 
spots near the membrane at one micron intervals (Figure 3.2).  These findings are in line 
with FA protein imaging previously published in our lab (115). 
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Figure 3.2 Zyxin staining at FA-like structures. Portal vein tissue was enzymatically 
dissociated into individual cells, fixed, and stained for zyxin.  Deconvolved cell center 
sections were examined by fluorescent microscopy.  Images showed zyxin staining in 
portal vein cells at regularly spaced one micron intervals near the membrane at FA-like 
structures indicated by white arrows.  Scale bar 10 m. 
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COLOCALIZATION 
Proteins that are known to localize to FAs in migrating cells were examined to 
confirm that these proteins associate with FAs in dVSMCs.  Furthermore, colocalization 
studies were undertaken to demonstrate that these FA proteins localized together, at the 
same FAs. 
Paxillin/pPax 
 To begin colocalization assessment, positive and negative controls were 
established for comparison.  As a positive control, freshly dissociated aorta cells were 
fixed and co-stained with antibodies against paxillin and phospho-paxillin (Figure 3.3).  
Paxillin phosphorylation at Y118 was selected since it is a known target of Src during FA 
activation in response to stimulation (147, 173).  Immunofluorescent imaging after 
stimulation showed paxillin localization in a filamentous pattern with regularly spaced, 
punctate spots of bright fluorescence near the membrane indicative of FA-like staining.  
The mostly punctate phospho-paxillin staining clearly made up a subset of the total 
paxillin staining. 
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Figure 3.3 Paxillin/pPax co-stain as positive control.  Enzymatically dissociated 
dVSMCs were co-stained for paxillin and phospho-paxillin after 10 min 10 M PE 
stimulation.  Deconvolved cell bottom sections were imaged for colocalization staining.  
Phospho-paxillin (green) stains a subset of overall paxillin (red) at regularly distributed 
FA-like punctae.  Blue staining is nuclear DAPI signal.  Scale bar 5 m. 
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Paxillin/pLC 
 As a negative control, paxillin, which localizes to FAs at the end of actin stress 
fibers (203), was co-stained in freshly isolated aorta cells with phospho-myosin light 
chain (pLC) (Figure 3.4). Myosin light chain phosphorylation at serine 19 was selected 
since myosin chains are expected to be localized with the contractile filaments in the 
interior of the cell and are not thought to interact with FA proteins.  In stimulated cells, 
the punctate staining of paxillin was clearly separable from the more filamentous pLC 
staining.  Paxillin staining showed distinct localization to the membrane with the 
predicted FA-like, regularly dispersed, bright punctate dots.  Phospho-myosin light chain 
staining, on the other hand, appeared more cytosolic and filamentous with brighter 
punctate dots at intervals along the filamentous stretches.  There appeared to be no 
significant overlap between the two protein populations, as expected. 
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Figure 3.4 Paxillin/pLC co-stain as negative control. Enzymatically dissociated 
dVSMCs were co-stained for paxillin and phospho-myosin light chain after 10 min 10 
M PE stimulation.  Deconvolved cell center sections were imaged for colocalization 
staining. Phospho-myosin light chain (green) punctae localized along intracellular 
filamentous structures do not overlap with overall paxillin (red), localized at bright 
punctae near the membrane. Blue staining is nuclear DAPI signal.  Scale bar 5 m. 
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Zyxin/Paxillin 
 As previously discussed, zyxin and paxillin are both known to localize to FAs in 
migrating cells.  Immunoflourescent imaging in dVSMCs appeared to show localization 
of both zyxin and paxillin at FA-like structures (Figures 3.2 and 3.4 respectively).  If they 
localize at FAs in dVSMCs, I would expect them to localize at some of the same FAs and 
therefore demonstrate at least partial colocalization in imaging experiments.  To test this 
hypothesis, freshly dissociated dVSMCs were co-labeled with antibodies against zyxin 
and paxillin and viewed under fluorescence microscopy (Figure 3.5).  Both zyxin and 
paxillin again, individually showed the typical FA-like, punctate staining pattern near the 
membrane.  A deconvolved, merged center section showed zyxin and paxillin dots at 
approximately one micron intervals near the cell membrane.  These dots either 
colocalized (at the 140 nm resolution of deconvolution microscopy (149)) or were closely 
adjacent to each other. 
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Figure 3.5 Zyxin and paxillin colocalize. Enzymatically dissociated dVSMCs were co-
stained for zyxin and paxillin.  Deconvolved cell center sections were imaged for 
colocalization staining.  Zyxin (red) and paxillin (green) show partial overlap at FA-like 
structures near the membrane (white arrows).  Where they do not overlap, paxillin and 
zyxin punctae localize adjacent to each other next to the membrane. Blue staining is 
nuclear DAPI signal.  Scale bar 10 m. 
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Zyxin/Vinculin 
 Previous studies in migrating cells have shown that zyxin and vinculin colocalize 
at FAs (104, 135).   Therefore, I performed colocalization studies for these two proteins 
in dVSM.  Immunofluorescent co-staining of freshly dissociated dVSMCs with 
antibodies against zyxin and vinculin revealed partial colocalization similar to that seen 
with zyxin and paxillin (Figure 3.6).  Vinculin staining appeared brightest at regular 
punctate regions bordering the cell membrane.  Likewise, zyxin staining was strongest at 
FA-like punctae at the cell membrane.  A deconvolved, merged image section clearly 
showed partial overlap of some of the distinct vinculin and zyxin punctae. 
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Figure 3.6 Zyxin and vinculin colocalize. Enzymatically dissociated dVSMCs were co-
stained for zyxin and vinculin.  Deconvolved cell center sections were imaged for 
colocalization staining.  Zyxin (red) and vinculin (green) show partial overlap at FA-like 
structures near the membrane (white arrows).  Where they do not overlap, vinculin and 
zyxin punctae localize adjacent to each other next to the membrane.  Blue staining is 
nuclear DAPI signal.  Scale bar 10 m. 
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FAK/Vinculin 
 Finally, vinculin colocalization with FAK was examined.  FAK has been shown 
to be a major component of FAs in migrating cells (138).  For this reason, FAK and 
vinculin were chosen as another colocalization pair to compare the structure of FAs in 
dVSMCs to those in cultured cells.  Freshly isolated dVSMCs were co-stained with 
antibodies against FAK and vinculin (Figure 3.7).  FAK displayed easily identifiable 
bright punctate spots at regular intervals, particularly near the cell membrane. The 
brightest vinculin staining, although not as well localized in this set of images, was also 
punctate near the cell membrane.  A deconvolved, merged center section shows partial 
overlap of zyxin and FAK punctae, indicative of colocalization (Figure 3.7A).  This is 
especially evident in a merged cell image section taken near the top of the cell (Figure 
3.7B).  This section shows a “slice” off the top, essentially only showing protein 
localization near the membrane (and minimizing the cytosol or intracellularly localized 
fluorescent signal). 
  
60 
 
 
Figure 3.7 FAK and vinculin colocalize. Enzymatically dissociated dVSMCs were co-
stained for zyxin and vinculin and imaged by immunofluorescent microscopy.  (A) 
Deconvolved cell center sections were imaged for colocalization staining.  FAK (green) 
overlaps with a subset of vinculin (red) at FA-like structures near the membrane (white 
arrows). (B) Deconvolved cell top section showing FAK colocalization with a subset of 
vinculin staining (white arrows) at FA-like structures associated with a membranous top 
cellular slice.  Scale bar 10 m. 
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SUMMARY 
 Here I have shown that some of the same proteins that are known to associate 
with FAs in cultured, migrating cells also localize to FA-like structures in dVSMCs as 
shown by in immunofluorescent imaging of several FA proteins.  Furthermore, although 
each protein has its own unique staining pattern, at least a subset of each protein seemed 
to colocalize with the other FA proteins at distinct FA-like structures.  Taken together, 
this suggests that the protein make up and structure of FAs in dVSMCs is similar to the 
FA architecture in proliferating, migrating cell types.  However, this raises an important 
question.  How far do the similarities extend?  If FAs in dVSM are structurally related to 
FAs in other cell types, are they functionally analogous as well?  Or, alternatively, do 
FAs in dVSM use a common FA structural basis to accomplish functional tasks unique to 
their cell type? 
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CHAPTER 4: FOCAL ADHESION PROTEIN DYNAMICS 
 
INTRODUCTION 
 FAs are known to be highly dynamic structures in migrating fibroblasts (216, 
220).  Recent studies have suggested that they may be similarly dynamic even in fully 
differentiated cell phenotypes, just that their function may be different.  Research from 
the laboratory of Dr. Susan Gunst has shown a variety of FA proteins seemingly 
translocating in response to cholinergic agonists (148).  As a means of examining the role 
of FA proteins in VSM contraction, our lab has shown that Src inhibition by the small 
molecular inhibitor PP2 (10 M) (90, 125) or morpholino knockdown during tissue 
contraction (10 M PE) in serum free organ culture slows contraction and decreases 
steady-state contractile force amplitude (136). Recently, published work from our lab has 
also shown agonist-induced redistribution of VASP (115). I suspected that these were not 
isolated examples and wanted to investigate whether other FA proteins, particularly those 
that are thought to be associated with VASP, might be exhibiting dynamic redistribution 
and whether this movement has any effect on contractile function. 
 
IMAGING IN UNTREATED VS. PE STIMULATED CELLS 
I tested the hypothesis of FA protein translocation using those techniques that 
have already proven successful in this field.  I began by looking for visible signs of 
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stimulus-induced redistribution through immunofluorescent imaging.  Freshly 
enzymatically dissociated cells were left untreated or stimulated with 10 M PE for 10 
minutes, stained for zyxin, and then inspected for changes in location, intensity, or other 
staining patterns.  Unfortunately, these experiments did not show any consistent 
difference between untreated and PE-treated cells (Figure 4.1).  This could be because 
high background staining masks slight changes, that this type of immunofluorescent 
analysis is simply not sensitive enough to observe change, that the pool of dynamic 
proteins is too small to be detected this way, or that the proper landmarks were not used 
to detect movement. 
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Figure 4.1 Immunofluorescent staining reveals no visible movement of zyxin in 
response to PE.  Freshly dissociated ferret aorta cells stained with antibodies for zyxin, 
with (bottom panel) or without (top panel) 10 minutes of 10 M PE, treatment reveal no 
obvious visual evidence of movement.  Deconvolved center sections were used for 
analysis.  Blue staining in the top panel is nuclear DAPI signal.  Empty, dark area of the 
cell in the bottom panel is probably occupied by the nucleus, but this cell was not stained 
with DAPI to confirm.  Scale bar 10 m. 
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DIFFERENTIAL CENTRIFUGATION 
 Assays up to this point had failed to reveal any significant agonist-induced 
changes in VSM contraction.  So, I chose to expand on previously successful procedures 
in our lab which took advantage of multiple tissue fractions.  Kim and colleagues in our 
laboratory have used two-fraction differential centrifugation to demonstrate phorbol ester 
agonist induced redistribution of VASP (115).  I sought to confirm and expand these 
findings with a two and then three-fraction analysis of several FA proteins.  
DPBA 
Differential centrifugation of aortic tissue homogenates was used to separate 
proteins into soluble (cytosolic, Cyt) and Triton X- insoluble (cytoskeletal, Csk) 
fractions. FA-associated proteins in the tissue fractions were identified by immunoblot 
and the results analyzed for changes in the distribution between fractions in response to 
the phorbol ester, DPBA.  Results confirmed the previously seen shift of VASP from 
cytosol to cytoskeleton.  Furthermore, my data show, for the first time, a significant shift 
from cytosol to cytoskeleton of zyxin and metavinculin, and a similar trend for vinculin 
and CAS but no change for alpha-actinin and actin (Figure 4.2).  There is a certain degree 
of variability in the method that may have prevented vinculin and CAS from reaching 
statistical significance. 
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Figure 4.2 Phorbol ester DPBA triggers redistribution of some FA proteins. 
Densitometric analysis of western blots of FA proteins in cytosolic (Cyt) and cytoskeletal 
(Csk) fractions normalized as a percentage of the total protein amounts from unstimulated 
(Rest) or DPBA (10 μmol/L) stimulated (Stim) tissues (n=5). *p<.05 as determined by a 
two tailed, paired t-test compared to resting values. 
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PE 
After successfully demonstrating translocation with DPBA, I wanted to expand on 
my findings by establishing a differential centrifugation protocol that would result in 
three fractions (cytosolic, membrane, and cytoskeletal) using the more physiologically 
relevant vasoconstrictor, phenylephrine (PE). 
Total gel stains 
To confirm the validity of this procedure and proper segregation of the fractions, a 
Coomassie blue-stained protein gel of the three fractions at four different treatment time 
points (unstimulated (unstim), 10 mol/L PE for 2 min, 5 min, and 10 min) was run and 
indicates, as expected, that a large proportion of total cellular protein was located in the 
cytoskeletal (SK) fraction at all time points (Figure 4.3A). Average densitometry from 
such gels is shown in Figure 4.3B, where it can be seen that more than half of the overall 
protein was in the cytoskeletal fraction.  
As positive controls, three proteins with known intracellular distributions were 
examined by western blot (Figure 4.3C). As expected, about 80% of GAPDH was in the 
cytosolic (C) fraction (Figure 4.3D), in agreement with previous findings (143). Almost 
40% percent of Rab5, a marker protein for early endosome recycling (23, 83, 190), was 
in the membrane (M) fraction (Figure 4.3E). About 60% of total cellular actin is in the 
cytoskeletal (SK) fraction (Figure 4.3F) as has been found by others (147) and it was 
largely unchanged under these conditions.  
  
68 
 
 
 
  
69 
 
Figure 4.3 Differential centrifugation of dVSM tissue distinguishes known 
cytoskeletal proteins from membrane and cytosolic proteins. (A) Typical Coomassie 
stained blot of proteins in fractions (kD, kilodaltons). (B) Graph of quantitative 
densitometry from panel A. n=3. cytosolic (C), membrane (M), and cytoskeleton (SK) 
(C). Western blots of unstimulated or PE-(10 μmol/L) stimulated tissues of three different 
proteins typically associated with the three different subcellular compartments of interest. 
(D,E,F). Quantitative densitometric analysis of western blots of total GAPDH, Rab5, and 
Actin (n=3-11), proteins characteristically associated with cytosol, membrane, and 
cytoskeleton respectively. Brightness has been uniformly altered for visual display. 
*p<.05 as determined by a two tailed, paired t-test compared to resting values. 
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In addition, after differential centrifugation of 6 different aortic rings from 2 
different animals, the final pellet was further solubilized in 1N NaOH. The recovered 
protein from the pellet made up 5.9% +/- 0.97% of the total protein based on 
densitometric analysis of Coomassie gel stains. The remaining protein in the pellet was 
likely residual unbroken nuclei and chromatin as well as highly insoluble ECM proteins 
like elastin. To confirm this was the case, immunoblot analysis of pellet fractions 
(solubilized in 1N NaOH) after differential centrifugation of both resting and PE-treated 
tissue was performed and the data show that the pellet contributed an average of 0.43% 
+/- 0.17 overall zyxin and an average of 0.57% +/- 0.25 overall VASP indicating 
negligible loss during differential centrifugation.  
Remodeling proteins 
- Some FA proteins move out of the cytosolic fraction 
Differential centrifugation of aortic tissue homogenates was used to separate 
proteins into soluble (cytosolic), Triton X-soluble (membrane), and SDS-soluble 
(cytoskeletal) fractions. FA-associated proteins in the tissue fractions were identified by 
immunoblot (Figure 4.4A) and the results analyzed for changes in the distribution 
between fractions in response to the vasoconstrictor, PE. Zyxin, a FA protein (44) that 
facilitates actin filament elongation in response to mechanical forces in cell culture (97), 
resides to a large extent in the cytosolic fraction in dVSM (Figure 4.4B, left panel). 
Between 2-10 minutes after addition of PE, zyxin redistributed, leaving the cytosolic 
fraction (83% to 56%) and increasing in both the membrane and cytoskeletal fractions. At 
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10 minutes, zyxin levels increased fourfold in the membrane fraction and doubled in the 
cytoskeleton (Figure 4.4B, right panel).  No statistical significance was calculated for 
graphs normalized to resting protein since such a procedure eliminates experimental 
variability in unstimulated protein levels. 
VASP, a protein that binds to and is targeted by zyxin (50), behaved similarly to 
zyxin (Figure 4.4C, left panel). In the absence of a stimulus, about half of the total VASP 
localized in the cytosol, but after PE exposure, VASP gradually left the cytosolic fraction 
and redistributed to the membrane fraction. After 10 min of PE treatment, 12% of total 
VASP has shifted to the membrane fraction. This represents a 2.5 fold increase in the 
amount of protein in the membrane fraction (Figure 4.4C, right panel). Note that although 
Figure 4.4C suggests that the significant increase of VASP in the membrane fraction (left 
panel) at 2 and 5 minutes may come from a decrease in the cytosolic fraction, the 
variability in the method prevented us from making that conclusion since no statistically 
significant changes were observed in the VASP content of the cytosolic fraction at early 
time points. 
Metavinculin, a multifunctional FA signaling/crosslinking protein (Figure 4.4D) 
(135, 227), and paxillin, which interacts with FAK and promotes downstream signaling 
pathways (24, 202) (Figure 4.4E), similarly redistributed from the cytosolic to the 
membrane fraction upon addition of PE. Finally, vinculin and filamin showed small, but 
significant redistribution to the membrane as well (Figure 4.4 F,G). 
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Figure 4.4 The alpha-agonist PE triggers redistribution of zyxin, VASP, paxillin, 
filamin, and metavinculin/vinculin to the membrane fraction from the cytosolic 
fraction. (A) Typical blots illustrating the time course of PE stimulus-induced changes in 
protein subcellular distribution. Blank space is a spliced out empty lane. (B-G) 
Densitometric analysis of western blots of FA proteins in cytosolic, membrane, and 
cytoskeletal fractions normalized as a percentage of the total protein (left panels) or as a 
percentage of unstimulated protein (right panels) from unstimulated or PE-(10 μmol/L) 
stimulated tissues (n=4-17). Data for each experiment are from a single gel. Brightness 
has been uniformly altered for visual display. *p<.05 as determined by a two tailed, 
paired t-test compared to resting values. 
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- Some FA proteins move out of cytoskeletal fraction 
Not all FA-associated proteins exhibit the same redistribution pattern. It has previously 
been reported that CAS and Src, which are both signaling molecules associated with FAs, 
redistribute to the membrane from the cytoskeletal fraction (136). I have confirmed those 
data and showed increasing levels of CAS and Src in the membrane fraction over a time 
course of PE treatment (Figures 4.5A,B,C). The change in CAS was a small percentage of 
the total (11%) (Figure 4.5B, left panel), but this represented a 67% increase in the 
membrane fraction after 10 minutes of PE exposure (Figure 4.5B, right panel). It is also 
interesting to note that even though Src and CAS may be closely associated in the FA and 
exhibit similar relocalization patterns, their general intracellular distributions as measured 
by this method were quite different in that CAS in unstimulated samples was 46% 
cytosolic compared to just 14% for Src. 
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Figure 4.5 CAS and Src redistribute to the membrane fraction from the cytoskeletal 
fraction in the presence of PE. Time course of stimulus-induced changes in protein 
subcellular distribution. (A) Typical blots. Densitometric analysis of CAS (B) and Src (C) 
in cytosolic, membrane, and cytoskeletal fractions normalized as a percentage of the total 
protein amounts (left panels) or as a percentage of unstimulated amounts (right panels) 
from unstimulated or PE-(10 μmol/L) stimulated tissues (n=6-18). Data for each 
experiment are from a single gel. Blank space is a spliced out empty lane. Brightness has 
been uniformly altered for visual display. *p<.05 as determined by a two tailed, paired t-
test compared to resting values. 
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Static Proteins 
Notably, the FA protein FAK showed no significant PE-induced relocalization 
(Figure 4.6A,B). Furthermore, almost no FAK was detectable in the membrane fraction 
despite its known interaction with beta-integrins (180), transmembrane proteins that 
reside to a large extent in the membrane fraction in this assay (Figure 4.6C). These results 
suggest that FAK is more strongly bound to the actin cytoskeleton than to the integrin-
associated membrane (138). It is particularly striking that beta-integrin showed no 
noticeable agonist-induced redistribution with this assay (Figure 4.6A,C). This is in 
contrast to the well documented recycling of integrins in migrating cells (4, 165). This is 
suggestive of a qualitative functional difference of FAs between migrating and non-
migrating cells. 
The lack of detectable movement of alpha-actinin is also interesting (Figure 
4.6A,D). Since alpha-actinin is known to associate with zyxin (45), one might expect it to 
behave similarly. 
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Figure 4.6 FAK, integrin and alpha actinin show no detectable vasoconstrictor-
induced redistribution. (A) Typical blots. Densitometric analysis of FAK (B), beta-
integrin (C), and alpha-actinin (D) in cytosolic, membrane, and cytoskeletal fractions 
normalized as a percentage of the total protein amounts from unstimulated or PE-(10 
μmol/L) stimulated tissues (10 min) (n=4-12). Data for each experiment are from a single 
gel. Blank space is a spliced out empty lane. Brightness has been uniformly altered for 
visual display. *p<.05 as determined by a two tailed, paired t-test compared to resting 
values. 
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SUMMARY  
Here I have demonstrated the dynamic redistribution of several FA proteins in 
response to stimuli from two different agonists (VASP, zyxin).  Expanding my study to 
more FA proteins revealed a pattern of redistribution in response to PE.  However, there 
were several proteins (FAK, beta-integrin, alpha-actinin) that deviated from this pattern, 
and from what is known about their behavior in migrating cell phenotypes, by showing 
no redistribution.  This is indicative of a functional difference between the FA proteins in 
dVSM and other cell and tissue types.  Interestingly, the FA proteins that did redistribute 
in this assay all showed some degree of movement into the membrane fraction. 
  
79 
CHAPTER 5: FOCAL ADHESION PROTEINS AND ENDOSOMES 
 
INTRODUCTION 
The findings of agonist-induced redistribution of FA proteins were exciting and 
perplexing and raised questions.  If these proteins are moving, where are they moving and 
why?  Why do some move and not others?  Of particular interest was the realization that 
there is a consistent pattern of redistribution to the membrane, which was unexpected.  
Review of the literature showed that endosomal trafficking of some FA proteins was 
known to occur in non-muscle cells.  I hypothesized that redistribution to a membrane 
fraction might reflect FA protein recycling through association with an endocytic process. 
 
IMAGING 
Immunofluorescent Colocalization 
In order to see if the PE-induced redistribution of dVSM FA proteins to the 
membrane fraction observed here is linked with endocytic processes, I performed co-
localization studies for zyxin and endosome markers by deconvolution 
immunofluorescence microscopy of freshly enzymatically isolated aorta dVSMCs. Since 
zyxin is largely cytosolic, all images were uniformly thresholded to increase the 
resolution of zyxin at FA punctae and visually remove the cytosolic signal. As seen in 
Figure 5.1A, zyxin showed an increased degree of colocalization with Rab5, an early 
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endosome marker (23, 83), after PE stimulation. Zyxin staining at the cell edge that did 
not colocalize (arrowheads) likely represents FA localization. Zyxin colocalized with 
Rab5 in the cell interior (white arrows), consistent with endocytosis. Not all Rab5-labeled 
endosomes colocalized with zyxin. Similarly, not all zyxin is colocalized with Rab5, 
suggesting that only a fraction of total zyxin is in transition (which corroborates the 
results from differential centrifugation).  
I also tested whether zyxin colocalized with EEA1 (Figure 5.1B), another protein 
marker of early endosomes (39, 143, 184). EEA1 exhibited vesicular, punctate staining 
typical of endocytic vesicles and similar to that seen for Rab5. It also showed increased 
colocalization with zyxin after treatment with PE (white arrows).  Finally, using the vital 
cell membrane tracking dye FM4-64FX (92), I again saw increased colocalization of 
zyxin with the membrane dye after PE stimulation (Figure 5.1C).  
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Figure 5.1 FA marker protein zyxin shows increased colocalization with endosome 
markers in the presence of PE. (A) Immunofluorescent colocalization of Rab5 and 
zyxin before (left panel) and after (right panel) 10 min 10 μmol/L PE stimulation. Arrows 
indicate colocalization. Arrowheads show lack of colocalization and zyxin localization at 
FA-like structures. (B) Colocalization of zyxin and EEA1 before (left panel) and after 
(right panel) 10 min 10 μmol/L PE stimulation. Arrows indicate colocalized points. (C) 
Colocalization of zyxin and membrane tracking dye FM4-64FX before (left panel) and 
after (right panel) 10 min 10 μmol/L PE stimulation. Arrows indicate colocalized points.  
Blue staining is nuclear DAPI signal.  Scale bar, 5 μm. 
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Quantitative Colocalization 
Quantitative colocalization analysis was performed (Figure 5.2). Phalloidin and 
-actin colocalization was studied as a positive control, and -actin and DAPI 
colocalization was studied as a negative control. The percent of zyxin that colocalized 
with both Rab5 and EEA1, respectively, increased in a statistically significant manner 
after PE treatment, consistent with endocytic redistribution. In both cases, at least a 
doubling in the amount of colocalization was seen. As expected, the colocalization did 
not reach values seen with the positive controls, which would be indicative of complete 
colocalization (Table 5.1). 
  
83 
 
Figure 5.2 Zyxin colocalization with endosome markers increases after PE 
stimulation.  Graphical depiction of zyxin colocalization with two different endosome 
markers (Rab5, EEA1) shows significant increases after PE stimulation. Quantitative 
colocalization under both unstimulated and 10 min 10 M PE stimulated treatment 
conditions is at least 20% less than the positive control (-actin/phalloidin) (not complete 
colocalization) but at least 10% more than the negative control (-actin/DAPI).  *p<.05 
as determined by a two tailed, paired t-test. 
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Table 5.1 FA marker protein zyxin shows a quantifiable increase in colocalization 
with endosome markers in the presence of PE.  Data are the percentage of the first 
protein that colocalizes with the second protein +/- SE.  10-14 cells were analyzed in each 
case. See methods for further details. *p<.05 as determined by a two tailed, paired t-test 
compared to resting values. 
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Proximity Ligation Assay (PLA) 
Duolink proximity ligation assays (PLA) were performed on freshly isolated 
dVSMCs to determine the proximity (as an indicator of the potential association) of zyxin 
and EEA1 (70, 186, 187, 226). PLA results in easily detectable and quantifiable 
fluorescent dots when proteins are within 40 nm of each other (Figure 5.3A). There is 
some background nuclear autofluorescent signal in each cell also seen in previous studies 
(208). A negative control of incubating with the zyxin antibody alone, displayed a 
negligible number of fluorescent dots per m2 (n=17) (Figure 5.3B). In unstimulated 
cells, there was a statistically significant increase in the number of fluorescent dots 
compared to the negative control (n=31). This indicates that a certain subpopulation of 
zyxin and EEA1 resides close enough to each other to interact. After 10 minutes of PE 
stimulation, the amount of zyxin and EEA1 in close proximity increased 2.5 times 
compared to resting (n=41). The magnitude of this increase is similar to the PE-induced 
increase in fluorescent colocalization seen in Table 5.1.  Furthermore, zyxin and EEA1 
proximity dots appeared to be located in the cell interior (Figure 5.3A, bottom panel), 
which is suggestive of endocytic association. 
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Figure 5.3 The amount of zyxin and EEA1 in close proximity increases after PE 
stimulation. Confirmation by proximity ligation assay of close association that increases 
after 10 min PE stimulation. (A) Freshly dissociated dVSMCs were fixed and incubated 
with zyxin and EEA1 antibodies or zyxin alone as a negative control. Representative 
images of each condition are shown.  Scale bar, 10 m. Panels have been inverted to gray 
scale for better visualization. Cell outline based on visible light capture. See methods for 
further details. (B) The number of signal dots, as a measure for proximity of an antigen 
pair, was analyzed based on 17-41 cells per experimental condition in 3-5 independent 
experiments. *p<.05, **p<.01, ***p<.001 as determined by a two tailed t-test compared 
to resting values unless otherwise indicated. 
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SMALL MOLECULE INHIBITORS 
Primaquine 
Differential Centrifugation 
To further test the hypothesis that dVSMC FA proteins recycle through an 
endocytic mechanism, I used primaquine (PQ), a small molecule inhibitor of endosomal 
budding (95, 206).  PQ-treated samples showed, in all cases examined, a marked 
inhibition of the previously demonstrated PE-induced protein redistribution to the 
membrane fraction. In the presence of PQ and PE, the amount of zyxin and VASP in the 
membrane fraction returned to the levels seen in the absence of PE (Figure 5.4A,B). Src 
and CAS distributions were altered by PQ but to different degrees. Src levels in the 
membrane fraction were reduced with PE and PQ, but not to untreated amounts (Figure 
5.4C), perhaps reflecting association with nonvesicular membranes such as the 
plasmalemma. With CAS, levels in the membrane fraction returned to pre-PE levels in 
the presence of PE and PQ in a dose-dependent manner (Figure 5.4D). FA proteins with 
smaller overall redistribution to the membrane (paxillin, filamin, vinculin, metavinculin) 
all showed similar trends in response to PQ but did not all reach significance, probably 
due to the natural variability inherent within the methodology (Figure 5.4E,F,G,H).  PQ 
had no significant effect on membrane distribution of “static” proteins FAK, beta-
integrin, actin, or alpha-actinin (Figure 5.4I,J,K,L). 
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Figure 5.4 Primaquine blocks vasoconstrictor-induced membrane redistribution. 
(A-H) Pretreatment with two different concentrations of PQ reduce PE-induced protein 
redistribution to the membrane in response to 10 min 10 M PE stimulation. (A-D,G) 
Zyxin, VASP, Src, CAS, and vinculin all show significant inhibition of redistribution to 
the membrane after PQ treatment.  (E,F,H) Paxillin, filamin, and metavinculin trend 
towards inhibition of redistribution.  (I-L) FAK, beta-integrin, actin, and alpha-actinin 
show no significant changes in subcellular localization in unstimulated, PE stimulated, or 
PQ pretreated tissues.  N=4-18, +p<.05 compared to PE; *p<.05 compared to untreated.  
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Contractility 
To test the hypothesis that FA protein recycling may significantly modulate tissue 
contractility, dVSM tissue was treated with PQ while recording contractile force. One 
hour of 150 mol/L PQ pretreatment before PE stimulation noticeably altered tissue 
contractility (Figure 5.5).  
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Figure 5.5 Primaquine reduces aortic tissue contractility in serum free organ 
culture.  Force readout showing the marked reduction in speed and strength of tissue 
contractility in response to PE after pretreatment with PQ.  Blue colored trace (top) 
shows force exerted over time by a single 4mm aortic ring treated with 10 M PE.  Pink 
colored trace (bottom) shows force exerted over time by a 4mm aortic ring pretreated 
with 150 M PQ and then stimulated with 10 M PE. 
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A statistically significant slowing of the rate of force development apparent as 
almost a doubling of the time it takes for tissue to reach 50% of maximal contraction was 
seen (Figure 5.6A). Additionally, a statistically significant inhibition of steady state 
contractile force was seen with PQ pretreatment (Figure 5.6B). Since all force generated 
by the contractile filaments in dVSM is channeled through the FAs to be transmitted to 
the vessel wall, even a partial disruption of FA structure would be expected to impair 
contractile function. 
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Figure 5.6 Primaquine reduces contractility.  (A), Effect of PQ on the time to 50% 
steady state contraction amplitude. N=6, *p<.05. (B), PQ significantly reduces maximal 
steady state contractile force in response to PE stimulation. N=6, *p<.05. 
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Actin Polymerization Inhibitors 
Differential Centrifugation with Cytocholasin D 
It is known that actin polymerization and associated cytoskeletal remodeling in 
dVSMCs occurs during vasoconstrictor-induced regulation of tissue contractile function 
(115), and in cultured cells, it is known that actin dynamics play a role in some endocytic 
pathways, particularly early endosomal events (40, 53, 84). To test the hypothesis that 
actin dynamics might be involved in facilitating endocytic recycling of FA proteins in 
dVSM, tissue was treated with two inhibitors of actin polymerization. Concentrations of 
500 nmol/L and below of cytochalasin D are known to specifically inhibit actin filament 
elongation by capping the barbed ends while leaving the existing filaments intact (42). 
Treatment with cytochalasin D for one hour prior to PE stimulation had no effect on 
protein distribution for unstimulated tissue, but significantly inhibited PE-induced 
membrane redistribution of zyxin, VASP, paxillin and CAS (Figures 5.7A,B,C,D).  
Cytochalasin D had no effect on actin distribution (Figure 5.7E). 
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Figure 5.7 Actin inhibition with cytochalasin D blocks vasoconstrictor-induced 
redistribution to the membrane fraction. (A-D) Membrane fraction analysis after 
differential centrifugation of tissue samples that are either untreated, PE-stimulated, or 
Cytochalasin D pre-treated and PE-stimulated. (E) Actin shows no significant subcellular 
redistribution with or without Cytochalasin D pretreatment.  N=3-17, +p<.05 compared 
to PE; *p<.05 compared to untreated. 
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Differential Centrifugation with Latrunculin B 
Pretreatment with 0.1 mol/L latrunculin B, which inhibits actin branching by 
sequestering G-actin (43), had no effect on protein distribution for unstimulated tissue. 
However, in a manner similar to cytochalasin D, latrunculin pretreatment of PE-
stimulated tissue inhibited protein redistribution to the membrane fraction, with amounts 
in the membrane fraction returning to untreated levels (Figure 5.8A,B).  
Contractility 
 Cytochalasin D has already been shown to decrease PE-induced contractility in 
dVSM tissue (115), and a similar effect was seen with latrunculin B (Figure 5.8C). 
However, it is unclear based on these experiments, to what extent the effect on 
contractility can be attributed to endocytic processes as compared to other actin-
dependent processes. Altogether, however, these data point to a role for actin 
polymerization in the regulation of FA protein recycling. 
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Figure 5.8 Actin inhibition with latrunculin B blocks vasoconstrictor-induced 
redistribution to the membrane fraction. (A,B) Densitometric analysis of western blots 
stained for VASP and zyxin after differential centrifugation of latrunculin B treated tissue 
shows significant inhibition of PE-induced redistribution into the membrane fraction. 
N=3-19, +p<.05 compared to PE; *p<.05 compared to untreated. (C) 0.1 μmol/L 
Latrunculin B pretreatment for 1 hour significantly inhibits maximal tissue contraction 
strength. N=3, *p<.05. 
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Microtubule Network Inhibitor 
Colchicine 
It is known in proliferative cells that endocytic recycling relies on microtubule 
networks and their associated motors to transport vesicles throughout the cell (3, 130, 
189). To test the hypothesis that stimulus-induced FA reorganization also relies on a 
microtubule dependent endocytic recycling pathway in dVSMCs, I treated tissue with 
colchicine at two different concentrations to disrupt microtubule networks (66, 222). 
Treatment with colchicine for one hour prior to PE stimulation and differential 
centrifugation significantly inhibited previously observed PE-induced membrane 
redistribution in zyxin and VASP (Figure 5.9A,B).  
 These experiments confirm previous studies that indicate that colchicine does not 
significantly inhibit vasostimulator-induced contractile force [Figure 5.9C and (66, 222)]. 
However, increasing concentrations of colchicine had a significant slowing effect on the 
speed of force development (Figure 5.9D). At higher concentrations, it took twice as long 
to generate the same force. It is unclear, based on these experiments, to what extent the 
effect on speed can be attributed to endocytic processes as compared to other 
microtubule-dependent processes. Altogether, however, these data point to a role for 
microtubule networks in the regulation of both FA protein recycling and tissue 
contractility. 
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Figure 5.9 Microtubule inhibition with colchicine blocks vasoconstrictor-induced 
redistribution to the membrane fraction. (A,B) Densitometric membrane fraction 
analysis after differential centrifugation of tissue samples that are either untreated, PE-
stimulated, or 15 μmol/L colchicine treated and PE-stimulated. N=3-17, +p<.05 
compared to PE; *p<.05 compared to untreated. (C) Colchicine pretreatment at either 15 
M or 100 M concentrations for 1 hour did not affect maximal tissue contraction to PE; 
(D) Colchicine pretreatment did significantly increase the time to 50% maximal 
contraction in response to PE in a dose dependent manner. N=3, *p<.05. 
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SUMMARY 
Here I have shown a significant increase in the colocalization of zyxin with two 
different early endosome markers after treatment with PE.  This was accomplished both 
through quantitative immunofluorescent colocalization and PLA.  In addition, using a 
range of small molecular inhibitors to target and disrupt various stages of endocytic 
recycling resulted in a significant inhibition of the previously observed FA protein 
redistribution to the membrane.  PQ, a specific inhibitor of endosome budding, also 
severely disrupted normal tissue contractile response.  The actin and microtubule 
inhibitors I used (cytocholasin D, latrunculin B, Colchicine) induced similar effects, but 
to a lesser degree.  This may be due to pathway redundancies and off-target effects (actin 
and microtubule networks are involved in more than just endocytic pathways).  Taken as 
a collected whole, I believe these experiments present a compelling case for endocytic 
recycling as a means to redistribute FA proteins in dVSMCs as part of a contractile 
response. 
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CHAPTER 6: DISCUSSION 
 
A SUBSET OF FA PROTEINS IN DVSM REMODEL IN RESPONSE TO AN 
ALPHA-AGONIST  
The major finding of the present study is that a distinct subset of dVSM FA 
proteins redistribute in response to the vasoconstrictor, PE. In migrating cells the 
development and function of FAs has been extensively studied. FAs in proliferative cells 
provide structural and adhesive support as well as initiate signaling cascades. Typically, 
focal contacts coalesce at the leading lamellipodial edge, mature into anchoring FAs as 
the cell moves forward, and then completely break down as the leading edge migrates 
forward (151). In contrast, non-migratory dVSMCs have no need for complete FA 
turnover. However, it is known that dVSM cells display remarkable cytoskeletal 
plasticity, with the ability, when unrestrained and activated by an agonist, to shorten to 
50% of their initial length (204). Recycling/relocation of a subset of dVSM FA proteins 
may allow maintenance of plasticity of the connection to the contractile filaments while 
maintaining a stable FA protein core and a linkage to the matrix in the vessel wall. Such 
plasticity will also allow retention of the ability to quickly shift proteins to sites of high 
stress to strengthen and/or increase signaling responses without requiring an energetically 
costly and time consuming process of completely breaking down and rebuilding FAs in 
these non-synthetic, non-proliferative cells. It is well known that dVSMCs have low rates 
of protein synthesis compared to proliferative cells (115). Thus, it is more energetically 
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efficient for these cells to recycle proteins to sites where they are needed than to 
proteolyze proteins and then synthesize and target new proteins. 
 
MODEL FOR DVSM REMODELING DEPENDENCE ON FA ARCHITECTURE  
With super-resolution light microscopy (iPALM, a combination of photoactivated 
localization microscopy and simultaneous multi-phase interferometry of photons) the 
Waterman group has recently measured out a spatially layered architecture for FAs of 
mouse embryo fibroblasts (MEF) cells. They quantitated  “integrin signaling”, “force 
transduction”, and “actin regulatory” layers of proteins at increasing distance from the 
plasma membrane (107) (Figure 6.1). 
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Figure 6.1 Spatially layered model of focal adhesions. Interferometric photoactivated 
localization microscopy was used to map focal adhesion protein spatial distribution on a 
nanoscale level.  Based on the literature, FA proteins were separated into three functional 
groups: integrin signaling proteins, force transduction proteins, or actin regulatory 
proteins.  Based on average quantifiable z-distance from the membrane and known 
binding interactions in the literature, this model was generated.  Modified from 
Kanchanawong et al, 2010 (107). 
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The FA of the dVSM cell appears to display some features in common with this 
model but also exhibits some differences. If I use the PE-induced redistribution to the 
membrane fraction (Figure 6.2A) is used as an indicator of FA remodeling, then it 
appears that the proteins identified by Kanchanawong et al. to be associated with the 
integrin signaling layer (Figure 6.2B) undergo the least amount of remodeling (Figure 
6.2C). In dVSM, this is functionally appropriate, since shifting of critical FA proteins 
(especially beta-integrin and FAK) would constitute a major disruption of the integrity of 
the connection of the cell to the matrix of the vessel wall. This finding is also of interest 
since FAK has been reported to undergo an agonist-induced redistribution in airway cells 
from the cytosol to a cell surface distribution. The difference in these findings may point 
to functional and structural differences between the tissues (148). 
  
105 
 
Figure 6.2 Expected proximity to the plasma membrane suggests degree of 
redistribution to the membrane fraction. (A) Diagramatic representation of 
hypothesized role of endosomes in FA protein redistribution. Disconnected FA proteins 
are joined with budding vesicles which then fuse with early endosomes and are recycled 
to different FAs at the plasma membrane.  (B) Potential spatially-layered FA architecture 
based on Kanchanawong et al. model. The integrin signaling proteins, force transduction 
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proteins, and actin regulatory proteins are organized at increasing distance from the 
plasma membrane.  (C) Percent increase in the membrane fraction after 10 min 10 M 
PE stimulation compared to resting amounts. Proteins are arranged by expected distance 
from the plasma membrane based on Kanchanawong et al. model (107). 
 
Alpha-actinin also displayed a lack of detectable movement in these studies. 
Interestingly, alpha-actinin has been reported to translocate in imaging experiments in 
response to acetylcholine stimulation of tracheal smooth muscle (223). Therefore, the 
stationary nature of alpha-actinin in dVSM appears to demonstrate a difference between 
vascular and airway smooth muscle function. In fact, the general protein distribution 
pattern of alpha-actinin more closely resembles total actin (20% cytosolic, 20% 
membrane, 60% cytoskeleton) than VASP or zyxin (50% and 80% cytosolic, 
respectively) with which it is known to interact. However, most of the dVSM cellular 
actin is in the contractile filaments, and alpha-actinin is also a marker for the dense 
bodies into which the contractile filaments insert (63). Thus, in dVSMCs, alpha-actinin 
may be playing a larger role in the relatively less dynamic contractile filament domain 
than in the cortical non-muscle cytoskeleton/FA domain. 
On the other hand, VASP and zyxin, both of which have been identified by 
Kanchanawong et al. as components of the actin regulatory layer, exhibit the highest 
degree of remodeling. The large difference in mobility between the actin regulatory 
proteins and other FA proteins is suggestive of a disconnect, breaking-off point, or a 
point of release of the actin cytoskeleton from the FA, in response to PE. This is 
supported by the model suggested by Kanchanawong et al., indicating that zyxin and 
VASP lie on the outskirts of the FA, where they might more easily disengage. As 
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mentioned previously, alpha-actinin in dVSM may be playing a larger role in the dense 
bodies which insert into the less dynamic contractile filaments and, therefore, may not be 
as mobile as proteins associated with the cortical cytoskeleton. In keeping with the idea 
of a point of disconnect, there appears to be a second such point between the integrin 
signaling layer proteins and the force transduction layer proteins (Figure 6.2C). Proteins 
categorized as force transduction proteins, such as vinculin, display intermediate levels of 
mobility in our system as measured by membrane redistribution. They do not seem to 
disengage as easily as zyxin or VASP but also are not bound as immobile as the more 
integral FA proteins.  Again, in airway smooth muscle apparently greater redistribution of 
vinculin has been reported and the direction of movement was from the cell center to the 
cell surface, as determined by immunofluorescent imaging of freshly dissociated cells. 
This may reflect differences in tissue function or in methodology. Of note, Eddinger et al. 
also imaged vinculin in airway muscle and saw little or no agonist-induced redistribution 
in cryosections of frozen tissue as opposed to when freshly dissociated airway cells were 
studied (56, 57). 
 
FA PROTEIN REMODELING IS DEPENDENT ON ENDOCYTIC PROCESSES  
So, if cells are capable of both disengaging the actin cytoskeleton from FA 
proteins and FA proteins from each other and then reallocating them to sites of active 
tension and stress, the question arises as to how the proteins are transported. Another 
major finding of the present study is that endocytic recycling is necessary for PE-induced 
FA protein recycling in dVSM. Active endocytic pathways are known to be characteristic 
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of synthetic, migratory, proliferative cells, but here, for the first time, I show an essential 
role for endocytic processes in a non-proliferative, non-migratory, fully differentiated, 
contractile cell phenotype. Several studies have pointed to a connection between FA 
proteins and the endocytic pathway in cultured cells (176, 177, 200), which led me to 
hypothesize that dVSMCs might use endocytic pathways to disengage proteins from the 
FAs and shuttle/recycle them to regions with increased cellular tension. In support of this 
concept, immunofluorescence microscopy colocalization and PLA experiments showed 
that zyxin increased its colocalization with Rab5 and EEA1, early endosome recycling 
markers after stimulation with PE. Disruption of endocytic recycling with 150 mmol/L 
PQ caused a marked reduction in the speed of contraction as well as a decrease in 
contraction strength. It also eliminated or diminished the PE-induced redistribution of FA 
proteins, consistent with the concept of a connection between FA proteins, endosomal 
recycling, and the regulation of dVSM contractility. Fifty mmol/L PQ indistinguishably 
decreased the redistribution of zyxin, VASP, and Src, but caused a smaller inhibition of 
CAS redistribution and perhaps that of other FA proteins, which may explain why this 
lower concentration of the recycling inhibitor had a diminished effect on contraction 
speed and strength. 
Another surprising aspect of this study is that paxillin, often considered a FA 
marker and a known cytoskeletal protein that associates with FAs (203) in at least some 
non-muscle cells and in Schwann cells (34), was here found to be largely excluded from 
the cytoskeletal fraction. In the absence of a stimulus, 76% of total paxillin was in the 
cytosolic fraction and only 6% was seen in the cytoskeletal fraction. Similar results were 
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seen with vinculin. This agrees with earlier findings in small arteries but points to unique 
properties of the dVSM cells of the vascular wall.  
 
FORCE GENERATION AND MAINTENANCE IN DVSM IS ACTIN AND 
MICROTUBULE DEPENDENT  
I also report here that endosomal redistribution in dVSM is actin and microtubule 
dependent. Others in our group previously showed that actin filament elongation is 
necessary for normal vascular contractility and that a cortical, non-muscle actin 
population is involved (115). Recent studies have shown that increased membrane 
tension in MDCK cells increases actin dependency of clathrin-mediated endocytosis. By 
inhibiting actin polymerization with cytochalasin D or latrunculin B, endosomal 
trafficking in dVSM was impaired. The mechanism could involve an inhibition of the 
construction of actin tracks along which the endosomes might move, or it could involve 
inhibition of actin filament-mediated pinching off of new endosomes either by pushing 
the vesicle away from the plasma membrane or constricting the neck in an Arp 2/3 
complex-mediated mechanism (408, 480). The actin dependency may help identify the 
specific endocytic pathways involved, since not all endocytic pathways are dependent on 
actin polymerization (2, 20, 71, 84, 174). Similarly, endocytic dependency on 
microtubule networks has been well documented in cultured cells (3, 189), but here, for 
the first time, I report similar findings in dVSMC. 
 Thus, in the present study we report that FAs in dVSMCs embedded in the wall of 
the aorta remodel during the action of a vasoconstrictor and that the remodeling involves 
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an actin and microtubule-dependent endocytic pathway. These results may have 
significant implications for understanding the mechanisms underlying dVSM contractile 
function and vascular compliance and may provide new targets for drug discovery studies 
aimed at creating new therapeutics for the treatment of cardiovascular disease. 
 
FUTURE PERSPECTIVES/RESEARCH 
 Although the work done here extends our understanding of the mechanisms and 
processes involved in smooth muscle contraction and focal adhesion dynamics, it needs 
to be confirmed, focused and extended.  
Confirming FA Dynamics 
My findings would be bolstered by additional experiments confirming FA protein 
association with endosomes after stimulation.  This could be accomplished by 
demonstrating increased tethering of endosome markers with FA proteins after 
stimulation via immunoprecipitation.  Duplicating my findings with lower reversible 
concentrations of stimulants and demonstrating not only FA protein redistribution to the 
membrane, but also demonstrating reversal back to original protein distributions after 
relaxation, would strengthen my results further.  Live-cell imaging visibly showing FA 
protein redistribution, or immuno-gold EM imaging of FA proteins in membranous 
vesicles would also help support my hypothesis. 
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Focusing on FA Dynamics and Endocytic Recycling. 
 Despite my findings on FAs and endosomes, there is still much that remains to be 
clarified and elucidated.  Future work on FA dynamics could include comparing protein 
redistribution in normal vs. diseased models.  It would also be useful to expand the list of 
FA proteins studied to get a better sense of the overall picture and potentially clarify and 
delineate the specific “points of release.”  Once these have been more fully defined, 
specifically targeting binding sites that connect these points could reveal how important 
these connections are in contributing to FA remodeling and contractile response. 
 Endosome recycling is a complex process and it would be enlightening to 
determine the specific pathways involved in FA protein recycling (189).  By combining 
specific inhibitors of different steps of the various endocytic processes, I could develop a 
more precise picture of the pathways involved.  For example, inhibition with methyl--
cyclodextrin could help distinguish between clathrin and caveolae-dependent or 
independent endocytosis (51, 166, 191, 196).  Inhibition of specific molecular motors 
(kinesins, myosins, dynein, dynamins) could tell me which endocytic steps are involved 
(62, 130, 188).  Furthermore, could I increase the amount of FA recycling in response to 
stimulation by increasing lipid content or stabilizing microtubule networks (taxol)?  
Inducing endocytic trafficking at 20C prevents vesicle transfer from early to late 
endosome and would provide more specific data on which pathways are implicated (52, 
122).  Finally, tracking protein uptake (avidin or biotin) or subcellular distribution of 
fluorescent endocytic probes (transferrin, lactosylceramide) could provide information 
about the pathways involved (207).  
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Potential Clinical Applications. 
 By developing a better understanding of the importance of FA dynamics and 
endocytic recycling in regulating dVSM contraction, drug companies may be able to find 
new candidate targets for therapies (55).  Other work in our lab has already been 
successful developing specific, dominant-negative, cell-permeable peptide inhibitors 
(115).  A clearer understanding of the specifics of the endocytic pathways involved and 
which FA proteins are most important for contractile response in dVSM would give me a 
better idea of which proteins for which to design peptide inhibitors.  These findings could 
potentially provide new options for targeted drug therapies for alleviation of 
cardiovascular disease. 
 In addition, the FA protein complex in dVSM has similarities to the beta-
dystroglycan complex and costameres in skeletal muscle.  If some of my general findings 
are consistent across cell phenotypes, it could open avenues for new research into 
alleviation of various dystrophies. 
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